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Summary 
Onchocerciasis, also known as river blindness, is a tropical disease causing health 
and socioeconomic problems in endemic communities, especially sub-Saharan 
Africa. The disease is elicited by a filarial parasite called Onchocerca volvulus, 
which is transmitted by the bite of infected blackflies (Simulium). Characteristic 
disease symptoms include dermatological disorders and eye lesions that can lead 
to blindness. Two polar forms of clinical manifestations can occur: generalized 
onchocerciasis (GEO), presenting mild skin disease or the hyperreactive form 
(HO) which exhibits severe skin disorders and inflammation. Globally, 37 million 
individuals are estimated to be infected. The intensity of immune reactions against 
the parasite is believed to influence the clinical outcomes of the disease and the 
immune determinants that drive tolerance or pathology are still not fully 
characterized. Th17 cells are a distinct subpopulation of helper T cells with potent 
inflammatory properties and are characterized by their predominant production of 
interleukin (IL)-17 (IL-17A and IL-17F). These cells are implicated in several auto-
immune and inflammatory diseases. Commitment into Th17 cells or regulatory T 
cells (Treg) required almost the same pathway since both need TGF-β. IL-6 is one 
of the innate cytokines that determine the balance Th17/Treg. The present study, 
investigated the role of Th17 cells and the way the balance of Th17/Treg 
influences the outcome of clinical manifestations during human onchocerciasis. 
Moreover, the mechanisms underlying the plasticity between a regulatory 
phenotype and an inflammatory Th17 response was studied. Using a flow 
cytometry approach, this study investigated the expression patterns of Th1, Th2, 
Th17, Treg markers and other immune cells such as B cells, monocytes, CD8 and 
NK cells in peripheral blood mononuclear cells (PBMCs) from HO and GEO 
patients to putative immune/endemic normals (EN). The findings indicated that HO 
individuals exhibit strong Th2 and Th17 responses, as reflected by higher 
expression of IL-4, GATA3, and IL-17A, RORC2 expressing CD4 T cells when 
compared to either GEO or EN. Based on the enhanced numbers of IL-10-
expressing CD4+ T cells and CD4+CD25+Foxp3+ Treg, the work also showed that 
patients with GEO phenotype exhibited a regulatory milieu.  EN individuals on the 
other hand showed prominent Th1 (CD4+IFN-γ+ T cells). Flow cytometry data was 
further confirmed using a Th17 based PCR array. Th17-related genes such as IL-
17 cytokine family members as well as IL-6, IL-1β and IL-22, Th17 transcription 
factor and signalling pathway molecules (RORC2 and STAT3) and Th2-related (IL-
4, IL-13, STAT6) genes were all significantly up-regulated in HO individuals. 
Moreover, using in vitro cell cultures of PBMCs, this study further demonstrated 
that whereas Onchocerca volvulus-specific Th1 responses were increased in 
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cultures from EN, a strong Th2 phenotype was observed in cultures from HO 
individuals due to elevated levels of filarial-specific IL-5 and IL-13. To further 
investigate the mechanism underlying the differences between GEO and HO, an in 
vitro Th17 cell polarization model was performed and provided initial evidence that 
the commitment to a Th17 lineage could be modulated in PBMCs from GEO 
individuals by the addition of innate receptor triggering. Interestingly, it was 
demonstrated that products of innate stimulation, such us IL-6 and IL-1β, could 
also modify the GEO phenotype into one reflecting that from HO individuals. For 
the first time, this study provides evidence that elevated frequencies of Th2 and 
Th17 cells and the balance of Th17/Treg form part of the immune network 
instigating the development of severe pathology in human onchocerciasis. At the 
end a mechanism elucidating possible pathways that drive GEO and HO 
phenotype was proposed. 
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Zusammenfassung 
Bei der Onchozerkose, die auch Flußblindheit genannt wird, handelt es sich um 
eine tropische Erkrankung, die sowohl gesundheitliche als auch 
sozioökonomische Probleme in den betroffenen Endemiegebieten verursacht, 
darunter vor allem in Afrika südlich der Sahara. Die Erkrankung wird durch die 
parasitische Filarie Onchocerca volvulus hervorgerufen, die während des Stichs 
einer infizierten Kriebelmücke (Simulium) übertragen wird. Charakteristische 
Symptome der Erkrankung umfassen dermatologische Beschwerden und 
Augenläsionen, letztere können zur Erblindung führen. Es treten zwei polare 
klinische Formen der Infektion auf: eine generalisierte Onchozerkose (GEO) mit 
einer milden Hauterkrankung oder eine hyperreaktive Form (HO), die durch heftige 
Hautbeschwerden und Entzündungsreaktionen gekennzeichnet ist. Weltweit sind 
schätzungsweise 37 Millionen Menschen infiziert. Man geht davon aus, dass die 
Intensität der Immunreaktionen gegenüber dem Parasiten den klinischen Verlauf 
der Erkrankung beeinflusst, aber die bestimmenden Faktoren, die entweder eine 
Toleranz oder eine Pathologie induzieren, sind noch nicht vollständig 
entschlüsselt. Th17 Zellen sind eine bestimmte Subpopulation der T-Helferzellen 
mit potentiell inflammatorischen Eigenschaften. Sie werden durch ihre 
vorherrschende Produktion von Interleukin (IL)-17 (IL-17A und IL-17F) 
charakterisiert und sind an vielen autoimmunen und inflammatorischen 
Erkrankungen beteiligt. Die Entstehung von Th17 und regulatorischen T-Zellen 
(Treg) umfasst einen ähnlichen Entwicklungsweg, da beide TGF-β benötigen. IL-6 
ist eines der innaten Zytokine, welches das Gleichgewicht zwischen Th17/Treg 
determiniert. In der vorliegenden Doktorarbeit wurde die Rolle von Th17 Zellen 
während der humanen Onchozerkose untersucht und wie die Balance von 
Th17/Treg Zellen die klinische Erscheinungsform der Erkrankung beeinflusst. 
Darüber hinaus wurde der Mechanismus analysiert, dem die Plastizität zwischen 
dem regulatorischen Phänotyp und der inflammatorischen Th17 Antwort zugrunde 
liegt. In dieser Studie wurden mit Hilfe der Durchflusszytometrie die 
Expressionsmuster von Th1, Th2, Th17 und Treg Markern und weiterer 
Immunzellen, wie B-Zellen, Monozyten, CD8 und NK Zellen innerhalb der 
peripheren mononukleären Zellen (PBMCs) von HO und GEO Patienten 
untersucht und mit denen von putativ immunen/endemisch normalen (EN) 
Individuen verglichen. Die Ergebnisse zeigten, dass HO Patienten im Vergleich zu 
GEO und EN Individuen eine stärkere Th2 und Th17 Antwort besitzen, die durch 
eine erhöhte Expression von IL-4, GATA3, IL-17A und RORC2 exprimierenden 
CD4 T-Zellen gekennzeichnet ist. Diese Arbeit konnte ebenfalls demonstrieren, 
dass Patienten mit einem GEO Phänotyp ein regulatorisches Milieu aufweisen, 
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welches auf einer erhöhten Anzahl von IL-10 exprimierenden CD4+ T-Zellen und 
CD4+CD25+Foxp3+ Treg basiert. Im Gegensatz dazu zeigten EN Individuen eine 
prominente Th1 (CD4+IFN-γ+) T-Zellantwort. Die durchflusszytometrischen 
Ergebnisse wurden weiterhin mit Hilfe eines Th17 PCR Arrays bestätigt. Th17 
zugehörige Gene, darunter Zytokine aus der IL-17 Familie, IL-6, IL-1β, IL-22, Th17 
assoziierte Transkriptionsfaktoren und Signalwegmoleküle (RORC2 und STAT3) 
und Th2 zugehörige Gene (IL-4, IL-13, STAT6) waren alle signifikant in HO 
Individuen hoch reguliert. Des Weiteren konnte in dieser Studie mit Hilfe von in 
vitro Zellkulturen mit PBMCs dargestellt werden, dass Onchocerca volvulus-
spezifische Th1 Antworten in Kulturen von EN erhöht waren, wohingegen ein 
starker Th2 Phänotyp in Kulturen der HO Individuen vorlag, der durch gesteigerte 
filarienspezifische IL-5 und IL-13 Spiegel deutlich wurde. Um weiterhin den 
Mechanismus zu untersuchen, der zu den Unterschieden zwischen GEO und HO 
Individuen führt, wurden in vitro Th17 Polarisierungsexperimente durchgeführt. 
Diese erbrachten den Nachweis, dass eine Polarisierung in Richtung der Th17 
Linie in PBMCs aus GEO Individuen durch die Stimulation innater Rezeptoren 
moduliert werden kann. Interessanterweise konnte gezeigt werden, dass Produkte 
der innaten Stimulation wie z.B. IL-6 und IL-1β ebenfalls den GEO Phänotyp so 
verändern konnten, dass er demjenigen der HO Individuen entsprach. Zum ersten 
Mal konnte diese Arbeit aufzeigen, dass eine erhöhte Frequenz von Th2 und Th17 
Zellen sowie das Gleichgewicht zwischen Th17/Treg Zellen einen Teil des 
immunologischen Netzwerkes bilden, der die Entwicklung von schweren 
Pathologien initiiert. Anhand dieser Ergebnisse wurde ein möglicher Mechanismus 
skizziert, der die Entstehung der unterschiedlichen Phänotypen von GEO und HO 
Individuen erklärt.  
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1. Introduction 
Filariae are a distinct group of parasitic nematodes that can infect all classes of 
vertebrates other than fish [1-3]. The name filarial is derived from the Latin word 
filum meaning thread and refers to the thread-like morphology of the worms [2, 3]. 
They share similar features, including an adult stage that resides outside of the 
digestive tract, the requirement of an obligatory intermediate host (hematophagus 
arthropod) and the release of microfilariae into the definitive host [3, 4]. Eight 
filariae elicit lymphatic and tissue filariasis in human. Over 140 million people are 
infected with Wuchereria bancrofti, Brugia malayi, B. timori that elicit lymphatic 
filariasis. Onchocerca volvulus, Loa loa, Mansonella perstans, M. streptocerca and 
M. ozzardi are responsible for eliciting tissue filariasis. According to recent 
estimation, more than 200 million individuals are infected with lymphatic filariasis 
and onchocerciasis. A common characteristic of infections with filarial nematodes 
is that they enter the host silently and persist many years by manipulating host 
responses and inducing evasion strategies to avoid overt responses by the host's 
immune system [5-8]. In the majority of infected individuals, there is a striking 
absence of disease. However, there are several million infected people who 
develop pathological forms of disease that have grave socioeconomic 
consequences [7, 9-11]. The disability-adjusted life years (DALYs) are estimated 
to be in the region of 6.3 million years for lymphatic filariasis and onchocerciasis 
[12-16]. All filariae that can infect humans are classified into two main groups: 
filarioidae or Onchocercidae [17]. This thesis focuses on Onchocerca volvulus, a 
nematode which belongs to the family of Onchocercidae [17].  
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1.1.  Human onchocerciasis 
The genus Onchocerca contains several species such as O. ochengi, O. dukei, O. 
gibsoni  which infect cattle and O. volvulus which is responsible for onchocerciasis 
in man[18]. Onchocerciasis, commonly known as river blindness, is a filarial 
infection of the eyes and skin and is transmitted through bites of Onchocerca 
volvulus-infected black flies (Simulium spp) [19]. This section provides an overview 
about our current understanding of parasite distribution and epidemiology,  life-
cycle, clinical manifestations, diagnostics and treatment of the disease. 
1.1.1. Distribution 
In 2012, approximately 130 million people were at risk of infection in 27 African 
countries [20]. The 3 countries with the largest "at risk" population are Nigeria (37 
million), the Democratic Republic of the Congo (30 million) and Ethiopia (8 million) 
[20, 21]. Although 99% of infected people live in Africa, small pockets of 
endemicity can be found in Yemen and Central and Southern America [22]. Over 
37 million people are currently infected and within those, around 1% develop 
hyperreactive forms of the disease [4, 7]. Figure 1.1 depicts the global distribution 
of the disease. 
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Figure 1.1: Geographical distribution of human onchocerciasis.  
The distribution of onchocerciasis is linked to the location of blackflies which are naturally found 
close to  fast-running streams and rivers in the inter-tropical zones(red). About 90% of disease 
cases occurs in Africa. Onchocerciasis is also found in six countries in Latin America and in Yemen 
in the Arabian Peninsula. Image obtained from 
http://www.who.int/blindness/partnerships/onchocerciasis_disease_information/en/  
 
1.1.2. Onchocerca volvulus life cycle 
The life cycle begins when a parasitized female black fly of the genus Simulium 
takes a blood meal. During this blood meal, third-stage filarial larvae are released 
onto the skin of the human host, where they penetrate into the bite wound [7]. The 
larvae then develop into adult filariae in subcutaneous tissues and commonly 
reside within nodules in the subcutaneous connective tissues. Female adult worms 
can live in these nodules for approximately 15 years [4]. Male worms visit the 
nodules for mating. Adult females release approximately 1000 to 3000 
 microfilariae per day over 
completed when microfilariae 
After ingestion, the microfilariae migrate from the blackfly's midgut through the 
hemocoel to the thoracic muscles. The microfilariae then develop into first
larvae (L1) which mature over 
larvae (L3) [7]; thereby completing the life cycle
complete life-cycle of Onchocerca volvulus
Figure 1.2 Life-cycle of Onchocerca volvulus
Adult filarial worms release millions of microfilariae into the s
feeding Simulium blackfly vectors. Within the vector's midgut, the parasite metamorphosis's into L1 
and then L3 larvae. The latter are released into the human host during a further blood meal. Image 
from [26]. 
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a 9 to 14 year period [9, 10, 22, 23]
are taken up during a further blood meal 
a course of 10 to 12 days to infective stage three 
 [24-26]. Figure 
. 
 
kin which are taken up by blood 
. The cycle is 
[7, 23]. 
-stage 
1.2 illustrates the 
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1.1.3. Clinical manifestations 
The pathogenesis of filarial infection is characterized by acute and chronic 
inflammation [27-29]. Disease manifestation is believed to be provoked by the 
parasite, the host's own immune reaction and/or consequent additional infections. 
In human onchocerciasis, the clinical manifestations are thought to be associated 
with the destruction of the microfilariae in the skin and eyes [4, 30, 31]. The 
symptoms of disease manifestations are mainly keratitis, chorioretinitis and 
various forms of dermatitis [9, 23]. Infection characteristics have divided exposed 
and infected individuals into three groups: Generalised Onchocerciasis (GE0), 
Hyperreactive Onchocerciasis (HO) and putative immune/Endemic normals (EN) 
[32-34]. The GEO group encompasses a spectrum of clinical manifestations and 
host immune responsiveness and individuals present high parasite loads but mild 
pathology. Hyperreactive Onchocerciasis (HO) individuals on the other hand, have 
few worms but severe pathology [4, 6, 10, 35]. In endemic areas, putative immune 
(PI) individuals or endemic normals (EN) are persons, who despite permanent 
exposure to the parasite, remain without infection or clinical signs of disease [6, 
35]. 
1.1.3.1. Dermal pathology in onchocerciasis 
The principal site of infection is the skin which contains masses of microfilariae [4, 
36, 37]. Dying microfilariae can elicit a subcutaneous inflammatory response, a 
condition often called “lizard skin". Over time the skin may lose its pigmentation, 
which on dark skin gives rise to an appearance commonly referred to as “leopard 
skin”.  As mentioned above the majority of infected people develop the generalized 
form the disease, characterized by high worm and mf loads with mild skin 
inflammation. This is in contrast to the small group of individuals who develop a 
 localized or HO form of disease also known as sowda (Arabic word for black)
which refers to disease manifestations only on one side of the body 
Figure 1.3: Forms of diseases associated with human
 (A) Acute pustula onchodermatitis. (B, C) Chronic onchodermatitis. (D)= Dermatitis in Guatemala, 
erisipela de la costa. (E,F,G) Sowda with unilateral preference and dark skin as well as swollen 
femoral lymph node. (H) skin atrophy in 15
Lichenifield onchodermatitis. (L) Ocular onchocerciasis. 
http://www.cehjournal.org/article/vision
 
The sowda form was first described in Yemen
West Africa [39] and eastern Sudan 
cutaneous changes in acute papular, chronic papular and lichenified or reactive 
onchodermatitis, atrophy and depigmentation (leopard skin)
presents examples of skin lesion
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fibrous subcutaneous masses containing the adults worms termed 
onchocercomata (nodule) [6, 42]. The nodules vary in size from 1 to 5cm in 
diameter. The numbers of nodules vary and an infected individual may have as 
many as several hundred [42-44]. 
1.1.3.2. Ocular onchocerciasis 
Worldwide, onchocerciasis is the second leading cause of blindness stemming 
from an infectious origin. Microfilariae that migrate into the eye, and subsequently 
die there, can cause severe inflammation and scarring that can lead to impaired 
vision and blindness [23, 45, 46]. The severity of ocular pathology in distinct 
regions of West Africa is due in part to infection with different strains of the 
parasites [47, 48]. The life expectancy of a person who becomes blind in endemic 
areas may be shortened by about 10 years [23, 46, 48]. Onchocerciasis is also 
referred to as “river blindness” because of the blindness it causes and its 
association with habitation near rivers where blackflies breed [49, 50]. An 
illustration of ocular onchocerciasis is shown in figure 1.3. 
1.1.4. Diagnosis 
A physical examination or palpation of the patient can detect localized dermatitis 
or subcutaneous nodules. Usually, the presence of microfilariae is diagnosed by a 
biopsy of the skin called a skin snip. Microfilariae are spontaneously released from 
the skin when the skin snip is placed in a saline solution [43, 51, 52]. 
Subcutaneous nodules can also be surgically removed to identify the presence of 
adult worms [43, 44]. Polymerase chain reaction (qPCR) is a good approach used 
to diagnosis early infected people but such techniques are often impractical and 
expensive for local health care centres [53]. Immunodiagnostic tests such us 
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standard ELISA, dot blot ELISA and Western blot have also been developed to 
test for infection [54-56].  
1.1.5. Treatment 
The standard microfilaricidal drugs ivermectin and albendazole are used in mass 
drug administration programmes, with the aim of interrupting transmission. These 
programmes aim at reducing the burden of infection and, in some situations, 
leading to regional elimination of onchocerciasis [21, 57]. The recommended 
treatment for onchocerciasis is ivermectin (Mectizan®) [16, 21, 57, 58], which 
targets microfilariae and is fast-acting, safe, and effective. Ivermectin kills 
circulating microfilariae as well as those that are still in adult female worms; this 
reduces the numbers of microfilariae in the skin and the production of new 
microfilariae by adult worms so the disease does not progress [57, 58]. Standard 
treatment is once a year, but infected people can be treated up to three times in 
one year. Since adult worms are not killed and will continue to reproduce, 
treatment must continue for 10 to 15 years [21, 57, 59]. Before any treatment for 
onchocerciasis is begun, it is imperative to ascertain which individuals or 
communities are heavily infected with Loa loa, another filarial disease [57]. 
Ivermectin can provoke severe side effects, even death in patients with Loa loa 
[57]. In terms of macrofilaricidal drugs, the only safe option is the administration of 
antibiotics such us tetracyclines and doxycycline [60-65]. This therapy targets 
Wolbachia, the essential endosymbiont bacteria within the majority of filariae 
pathogenic to man. Wolbachia reside within the embryos of female worms and are 
required for their reproductive processes. Elimination of Wolbachia causes MF 
death and eventually destroys the worms as well [63, 66-69].    
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1.2.  Immunity in human onchocerciasis 
The host immune response towards onchocerciasis involves a range of innate and 
adaptive pathways [70-72]. Previous studies have noted a strong regulatory 
phenotype in generalized onchocerciasis individuals (high levels of IL-10, TGF-β, 
regulatory T cells and IgG4) and this immune balance is thought to be induced by 
the filariae to avoid effector immune responses [5-7, 73]. In contrast, HO patients 
display elevated IgE, IL-4 and severe symptoms of pathology. This section 
provides a brief synopsis about cell subtypes involved in human onchocerciasis. 
1.2.1. Macrophages and monocytes 
Monocytes circulate in the blood and are the precursors of macrophages [74, 75]. 
Macrophages are a heterogeneous population of phagocytic cells that reside in 
most tissues of the body [76]. In general, there are two subpopulations of activated 
macrophages: The classically activated macrophages (M1 or CAM) which are 
activated through inflammatory signals such as IFN-γ and the alternatively 
activated macrophages (M2 or AAM) which are provoked through anti-
inflammatory conditions such as Th2 signals like IL-4 [77]. Helminth infections are 
known to induce a Th2 responses that polarize macrophages towards an M2 
phenotype [78]. In onchocerciasis, M2 macrophages appear to suppress the 
immune response against the parasites, promoting anergy and/or tolerance [79]. It 
has been hypothesized that M2 macrophages may facilitate the repair of tissues 
that have been mechanically damaged by helminths [80]. 
1.2.2. Granulocytes 
Granulocytes comprise of a granulated cytoplasm containing granules rich in 
immunomodulatory molecules. They can be subdivided into neutrophils, 
eosinophils, basophils and mast cells. Granulocytes play a key role in innate and 
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adaptive immunity and can secrete a wide variety of mediators without de novo 
protein synthesis [81]. The capability of granulocytes to release toxic cationic 
proteins is an effector mechanism against extracellular organisms such as 
helminths [81, 82], although these molecules have also been implicated in tissue 
damage [83]. Thus, granulocyte-mediated immunopathology has been observed in 
hyperreactive onchocerciasis individuals [42]. In helminth infections, ligation of 
parasite-specific immunoglobulins to Fc receptors initiates antibody-dependent 
cytotoxicity (ADCC) killing of the parasites [84]. The release of granule proteins 
can be induced through binding of antigen-IgE complexes to the high affinity IgE 
receptor (FcεRI) that triggers a tightly controlled phosphorylation cascade [85, 86]. 
Higher eosinophil numbers and their related factors (e.g. eosinophil cationic 
protein) and neutrophils were shown to be associated with MF individuals [51]. 
Further studies have implicated eosinophils in Onchocerca volvulus-induced atopic 
dermatitis and keratitis which was indicated by the release of granules such us 
Eosinophils-granule major protein [87, 88]. 
1.2.3. Natural Killer and Natural Killer T Cells 
Natural killer (NK) cells are innate lymphocytes that produce important amounts of 
immunomodulatory cytokines after their receptor engagement by glycolipid 
antigens presented in CD1 molecules [89]. Thus, NK cells play an important role 
during infection and mainly against intracellular microorganisms [90]. Different NK 
cell subsets have been determined according to the presence and expression 
intensity of CD3, CD16 and CD56 surface molecules [91]. Mostly, NK cells are 
referred as NKT cells or NK cells according to their expression or not of the T cell 
receptor molecule (CD3) respectively [91, 92]. Studies have addressed the 
potential for NK cells to either contribute to, or to modulate, immune responses to 
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helminths [92]. Antibody opsonisation of parasites can facilitate the activation of 
NK cells via the ligation of FcγRIII which lead to ADCC and lysis of the opsonised 
parasites [85, 92].  Babu  et al. demonstrated through in vitro cultures of PBMCs 
that NK cells can be activated by filarial parasites and subsequent cell death [93]. 
Reduced NK and NK T cell numbers have been observed in generalized 
onchocerciasis individuals [94]. 
1.2.4. B cells and Immunoglobulins 
B cells are a heterogeneous population of lymphocytes that can react to antigens. 
This antigen recognition can be in a T-dependant or T-independent manner [95, 
96] . In addition to antibody production, B cells perform other substantial roles 
such as antigen-presentation, co-stimulatory molecule signalling, and cytokine 
production. Nevertheless, the importance of B cells in driving a T dependent 
response can vary with the particular antigen and the type of immune milieu [97, 
98]. Humoral immunity has been shown to be involved in protective immunity in 
helminth infection. For instance, ADCC is an important mechanism by which 
parasites are killed [85]. Hence, during helminth infection a polarized Th2 
response induces B cells to produce IgE and IgG1 [6, 99]. These antibodies 
induce degranulation in eosinophils and other granulocytes and can activate the 
complement system which leads to the clearance of the infection [82, 85, 100, 
101]. In O. volvulus-infected individuals , the induction of IgG4 is associated with 
the regulatory phenotype in GEO patients [6, 73, 101, 102]. 
1.2.5. CD4 helper T cells 
CD4 helper T cells differentiate into various subsets of effector T cells that have a 
variety of functions. There are four main functional classes: Th1, Th2, Th17 and 
the regulatory T cells. They are distinguished principally by the release of specific 
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cytokines and up-regulation of unique transcription factors. Th1 cells are 
characterized by the secretion of IFN-γ and the transcription factor T bet; Th2 by 
IL-4, IL-5, IL-13 and GATA3; Th17 by IL-17A and RORC2 and regulatory T cells 
secrete IL-10 and/or TGF-β and express CD25 and Foxp3 [103, 104]. CD4+ T cells 
play an important role in the protection, susceptibility and modulation of human 
onchocerciasis. T cell immune responses to O. volvulus are very distinct in 
generalized, hyperreactive onchocerciasis and endemic normals [7, 10, 105]. For 
example, Th1 responses were observed to be associated with endemic normals 
whereas both Th1 and Th2 were linked to hyperreactive onchocerciasis [94, 106-
109]. In addition, individuals without skin lesions, have pronounced systemic Th2-
type responses with a trend of increasing intensity in the order of depigmentation, 
papular dermatitis, atrophy and lichenified dermatitis [110]. Immunohistology of 
ectopic secondary lymph follicles in subcutaneous nodules from patients with 
hyperreactive onchocerciasis showed the presence of CD3+CD45RO+ T cells in 
the mantle zone [42]. Immunosuppression in chronic onchocerciasis has been 
observed to be associated with antigen-specific Tr-1 cells [111] and also higher 
regulatory responses characterized by the presence of CD4+CD25+Foxp3+ T cells 
were shown in generalized onchocerciasis [6, 10, 112, 113]. Mitre el al. 
demonstrated that IL-10-producing CD4+ T cells were predominant in filarial-
infected patients [114].  The implication of Th17 responses in onchocerciasis has 
not yet been established but they have been shown to be involved in the 
pathogenesis of lymphatic filariasis and schistosomiasis [115, 116]. As mentioned 
above, GEO is associated with a strong regulatory phenotype and research 
predicts that these characteristic are induced by the helminth to avoid host effector 
 immune responses [5-7, 73]
that arise during human oncho
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across a large group of mild symptoms in people with high loads of bloodstream 
microfilariae (GEO) to a minority of severe pathological symptoms in HO [7, 8]. 
The next section will focus on the immunomodulation and immunopathology 
during human onchocerciasis. 
1.4. Immunomodulation 
The clinical manifestations of the disease is well illustrated in long-term exposed 
individuals. GEO individuals show elevated levels of immunoregulatory cytokines 
and cells types [117, 118]. Typical characteristics of the observed 
immunosuppression include antigen-specific hyporesponsiveness in T cells [119], 
increased IL-10 secretion which consequently increased IgG4 production in B cells 
[112, 120].  IgG4 is non cytolytic antibody that can compete with IgE and other 
IgGs for the Fc receptor binding site, therefore inhibiting degranulation of 
granulocytes as well as ADCC [121, 122]. The cellular basis of this 
immunomodulation observed in filariasis included elevated IL-10-producing CD25+ 
Tregs, CD4+ T cells that expressed high levels of glucocorticoid-induced TNF 
receptor family-related protein (GITR) and cytotoxic T lymphocyte antigen 4 
(CTLA-4) [123, 124], alternatively activated macrophages (AAM) with anti-
inflammatory properties [79]. This immunoregulation induced by O. volvulus 
compromises effector immunity but also protects the host from damaging 
immunopathology reactions [8].  
1.5. Immunopathology 
The pathological reaction and tissue damage observed in filarial infections is 
thought to be linked to the immune responses against the parasite [4, 23]. In 
lymphatic filariasis for example, Th1 and Th17 responses were observed to be 
associated with the lymphedema [8, 116]. In schistosomiasis, Th1 and Th2 
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responses were associated with hepatic granuloma formation [125, 126] while 
higher frequencies of Th17 cells were observed in S. haematobium-infected 
children [115]. In human onchocerciasis, patients with pronounced Th2 responses 
have reduced microfilaria load [7]. However, enhanced production of Th2-related 
cytokines and immunoglobulins such as IgE was observed in hyperreactive 
onchocerciasis and sowda [127]. The implication of Th17 responses in the 
pathological outcomes of human onchocerciasis remains to be elucidated.  
1.6.  Aim of the study 
The pathology and immunity in populations exposed to Onchocerca volvulus 
infection is very broad.  At one extreme there are individuals heavily infected with 
no or little pathology associated with regulatory responses and at the other 
extreme are hyperractive amicrofilaraemic individuals with severe pathology 
associated with higher Th2 responses. Th17 cells have been described as a 
distinct subpopulation of helper T cells with potent inflammatory properties and are 
characterized by their production of interleukin 17 (IL-17A and IL-17F). While the 
role of Th1, Th2, Treg, B cells and other innate cells has been well characterized 
in onchocerciasis patients, it is still unclear whether Th17 cells are involved in this 
pathology, therefore the expression patterns of Th1, Th2, Treg, Th17, B cells, 
CD8+ T cells, monocytes and NK cells in peripheral blood mononuclear cells 
(PBMCs) from endemics normal, generalized onchocerciasis and hyperreactive 
onchocerciasis was examined by FACS analysis. Moreover, filarial-specific 
cytokine responses in an in vitro cell culture system after stimulation with either 
OvAg or αCD3/αCD28 were investigated. The cytokines and antibodies from 
supernatants were analyzed by ELISA and FlowCytomix multiplex system. To 
confirm our data at the molecular level, gene expression of GEO and HO was 
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done using a PCR array. In order to investigate the modulation of Th17 response 
in GEO individuals, an in vitro system was setup by inducing Th17 cells 
polarization either in the presence or absence of OvAg. To further assess the part 
played by innate responses in the differential expression of Th17 responses, 
PBMCs from the study groups were activated with TLRs and NLRs ligands. 
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2. Materials and Methods 
2.1.  Materials 
2.1.1. Patients and Onchocerca volvulus infection free volunteers  
In 2011, blood samples were collected from O. volvulus-infected individuals and 
included both generalized onchocerciasis and hyperresponsive onchocerciasis 
forms. Samples were obtained from individuals living in an Onchocerca volvulus 
endemic region of Ghana (Dunkwa). Recruited individuals included adult men and 
women aged 18-55 who were recruited as part of the study entitled "Enhanced 
Protective Immunity Against Filariasis (EPIAF)", 
(http://www.filaria.eu/projects/projects/epiaf.html). Ethical clearance was given by 
the Committee on Human Research Publication and Ethics at the University of 
Science and Technology in Kumasi, Ghana and the ethics committee at the 
University Hospital of Bonn, Germany. For comparison, samples were collected 
from 16 O. volvulus infection free volunteers from the same area and are thus 
referred to here as endemic normals. Written informed consent was obtained from 
all individuals. 
2.1.2. Healthy donors 
To investigate the mechanisms underlining Th17 cell differentiation and its 
modulation by adult Onchocerca volvulus worm, blood samples were collected 
from healthy European donors and were kindly provided by the Institute for 
Experimental Haematology and Transfusion Medicine, University Hospital of Bonn, 
Germany. Ethical approval was obtained from the University Hospital of Bonn 
ethics committee. 
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2.1.3. Plastic and glassware 
Plastic and Glassware used in this study were obtained from either Eppendorf AG 
(Hamburg, Germany), Greiner (Frickenhausen, Germany) or Nunc (Roskilde, 
Denmark). 
2.1.4. Antibodies, microbeads and recombinant human proteins 
For in vitro studies, cytokines were obtained as purified recombinant human (rh) 
preparations: rhIL-1β and rhIL-6 were obtained from Immuno Tools (Friesoythe, 
Germany), rhIL-4, rhIL-10 and rhIL-4 from eBioscience (San Diego CA, USA). 
Human T-cell activator, anti-human CD3 and anti-human CD28 monoclonal 
antibody microbeads (αCD3/αCD28) were obtained from Invitrogen (Carlsbad, 
USA). All conjugated antibodies used for flow cytometry (FACS): anti-human CD4-
APC, CD3-PerCP-Cy5.5, CD16-FITC, CD56-PE, CD45RO-FITC, CD45RA-PerCP-
Cy5.5, CD8-APC, CD19-APC, CD27-FITC, CD25-PECy7, CD14-FITC, Foxp3-
FITC, T-bet-PE, GATA3-PE, RORC2-PE, IFN-γ-FITC, IL-4-FITC, IL-10-PE and IL-
17-FITC were obtained from eBioscience. 
2.1.5. Onchocerca volvulus adult worm antigen extracts (OvAg) 
A soluble antigen extract of Onchocerca volvulus worms was prepared as 
previously described [51]. Briefly, worms were isolated from nodules from infected 
people and frozen in liquid nitrogen. Frozen adult male and female worms were 
thawed and washed in petri dishes using 1xPBS (PAA, Pasching, Austria). Worms 
were then placed in a glass mortar (VWR, Langenfeld, Germany) and re-
suspended in 4ml of RPMI 1640 medium (PAA) without supplements and crushed 
until the solution was homogenous. The extract was then centrifuged for 10 min at 
300xg (4°C). The supernatant was then carefully transferred into a 50ml falcon 
tube. To determine the protein concentration, a Bradford Assay (see section 
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2.2.10.2) was performed (Advanced Protein AssayTM, Cytoscelecton, Denver, 
USA) and the extract was aliquoted and stored at -80°C until used. All steps were 
performed on ice under sterile conditions. Titration of the extract was done to 
determine the optimal concentration for cells stimulation. 
2.2. Methods  
2.2.1. Parasitological assessment 
Clinical diagnosis of O. volvulus infection was performed by examining suspected 
nodules and the skin. All infected individuals presented at least one nodule 
(onchocercomata) and skin lesions. All participants were screened for the 
presence of microfilariae (MF/mg skin). In short, two skin biopsies (1-3mg) from 
the upper part of each buttock were removed using a corneoscleral (Holth) punch 
(Koch, Hamburg, Germany), weighed with a Sartorius® electronic balance 
(Göttingen, Germany) and incubated in 100µl NaCl (0.9%) overnight at room 
temperature in 96 well microtiter plates. Thereafter, MF were diagnosed and 
counted at 63-fold magnification using an optical microscope (Leica Microsystems 
GmbH, Wetzlar, Germany) [43, 44]. MF load was calculated per mg of skin. Blood 
smears from all patients were screened for malaria infections using standard 
Giemsa staining protocols. Co-infections by other intestinal helminths and/or 
protozoa were diagnosed using standard methods on fresh stool and urine 
samples collected from all participants. Helminth eggs were investigated using the 
Kato-Katz thick smears technique [51]. Samples of individuals free of all other 
helminths infections and malaria were used. 
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2.2.2. Isolation and freezing of peripheral PBMCs from endemic normals and 
Onchocerca volvulus-infected individuals 
Venous blood was collected as previously described by Arndts et al. [51]. 
Thereafter, PBMCs were isolated using a ficoll gradient centrifugation method 
(LSM Lymphocyte, PAA) [128, 129]. In brief, 7ml of blood was transferred into 
Ficoll containing tubes (Greiner) and centrifuged for 20min at 800xg at room 
temperature. The resulting white cell layer was transferred into a new 50ml falcon 
tube and washed twice with sterile endotoxin-free PBS for 8 min at 400xg at room 
temperature and re-suspended in RPMI 1640 supplemented with 10% FCS (PAA) 
and 50µg/ml of gentamycin (PAA). PBMCs were then cryo-preserved and stored in 
liquid nitrogen until required [111].  
2.2.3. Isolation and freezing of PBMCs from healthy European donors 
PBMCs from healthy donors were separated from buffy-coats using the ficoll 
gradient centrifugation method described in section 2.2.2 with the following 
modification: 35ml of PBS diluted blood was added to a 50ml Falcon tube 
containing 15ml ficoll. 
2.2.4. Thawing of frozen cells  
Cryo-tubes containing frozen PBMCs from healthy donors were removed from 
liquid nitrogen and quickly thawed by rubbing the tube between the palms of both 
hands. Cells were then pipetted into a sterile 15ml falcon tube and washed twice 
with 10ml cell culture medium. Thereafter, the supernatant was discarded and the 
cell pellet was resuspended in medium and counted as described above. All steps 
were performed on ice. 
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2.2.5. Cell viability and counting 
After isolating PBMCs, cell viability was determined using trypan blue (Sigma-
Aldrich) staining approach. In short, cells were diluted 1:10 or 1:100 with 0.4% 
trypan blue. Thereafter, 10µl of diluted cells were counted using a cell counting 
haemocytometer (LO Laboroptik GmbH, Bad Homburg, Germany). Unstained cells 
(living cells) were counted and cell numbers were estimated per ml.   
2.2.6. Magnetic cell sorting of CD4+ T cells, CD4+CD25+ regulatory T cells, 
CD19+ cells and CD14+ cells 
In order to investigate the pathway used by OvAg to suppress Th17 cell 
polarization, CD4+ T cells, monocytes (CD14+) and B cells were isolated using 
specific microbeads and magnetic cell sorting technology (MACS) (Milteny Biotec 
GmbH (Bergisch Gladbach, Germany). To study the plasticity of Treg to Th17 
cells, regulatory T cells and B cells were also isolated using the same approach. 
All steps were performed according to the manufacturer’s instructions. CD4+ T and 
CD19+ B cells were separated by negative selection and CD14+ monocytes by 
positive selection. CD4+CD25+CD127dim regulatory T cells were isolated in a two-
step procedure using the CD4+CD25+CD127dim Reg. T cell isolation kit II. In short, 
the non-CD4+ and CD127hi cell fractions were first depleted followed by the 
positive selection of CD4+CD25+CD127dim regulatory T cells. The purity of the 
isolated cells was checked by flow cytometry using the BD FACS Diva™ (BD 
Biosciences, Heidelberg, Germany) as described in the following section. 
2.2.7. Cell characterization by flow cytometry 
To address immune cell profiles in PBMCs from Ov-infected individuals, stimulated 
cells and to determine the purity of isolated cell types, a Fluorescence Activated 
Cell analysis (FACS) was performed. Flow cytometry is a laser based technology 
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to measure the phenotypic characteristics of cells. It allows a multi-parametric 
analysis of the physical and/or chemical characteristics of single cells by passing 
an optical and/or electronic detection apparatus. In brief, flow cytometry includes 
three main subsystems, the fluidic, the optic and the electronic systems. Cells of 
interest were solved in a fluid solution to bring the cell in the right spot for the 
interrogation. The optic system provides an excitation source and therefore 
generates and collects light signals. These optical signals were converted to 
proportional digital signals in the electronic subsystem. 
2.2.7.1. Characterization of surface markers 
All reagents were obtained from eBioscience (see section 2.1.4.). Staining was 
done as previously described [130]. To determine the frequency of different 
lymphocyte populations in Onchocerca volvulus-infected individuals and endemic 
controls, 1×105cells/100 µl staining buffer were incubated in FACS buffer for 30 
min at 4°C with either 1) a cocktail containing anti-human CD3-PerCP-Cy5.5 
(clone: OKT3), CD16-FITC (clone: CB16) and CD56-PE (clone: CMSSB) for NK 
and NK T cells; 2) a mixture of anti-human CD4-APC (clone: OKT4), anti-
CD45RO-FITC (clone: UCHL1) and anti-CD45RA-PerCP-Cy5.5 (clone: HI100) to 
distinguish naïve and memory CD4+ T cells.; 3) CD8-APC (clone: SK1) and CD14-
FITC (clone: 61D3) for CD8 T cells and monocytes respectively or 4) CD19-APC 
(clone: HIB19) and CD27-FITC for memory B cells. CD14-FITC, CD19-APC, CD4-
PE, Foxp3-FITC and CD25-PE-Cy7 were used to assess the purity of isolated 
monocytes, B cells, T cells and regulatory T cells respectively for other in vitro 
based co-culture assays. 
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2.2.7.2. Characterization of intracellular markers 
To assess levels of transcription factors and cytokines produced by helper T cell 
subsets, cells were activated with a "Cells stimulation cocktail" purchased from 
eBioscience, which contained Phorbol 12-myristate 13-acetate (PMA), Ionomycin 
and protein transport inhibitor (Brefeldin A and Monensin) for 6 hours.  Thereafter, 
surface staining was performed using anti-human CD4-APC (clone: OKT4) and 
cells were split into 5 groups: single staining of CD4+ T cells to observe 
background cytokine production levels and to navigate the gating strategy; stained 
for Th1, Th2 and Th17 or additionally surface-stained with CD25-PECy7 (clone: 
BC96) to determine regulatory T cells. After a 30min incubation at 4°C, cells were 
washed once in FACS buffer. After fixation and permealibization in 1/4x Fix-Perm 
reagent (eBioscience), cells were incubated at 4°C for 30 minutes with either 1) 
anti-human T-bet-PE (clone: eBio4B10) and IFN-γ-FITC (clone: 4S.B3) for the Th1 
panel; 2) GATA3-PE (clone: TWAJ) and IL-4-FITC (clone: B-S4) for Th2 cells; 3) 
RORC2-PE (clone: AFKJS-9) and IL-17A-FITC (clone: eBio64DEC17) for a Th17 
phenotype and or 4) Foxp3-FITC (clone: 236A/E7) and IL-10-PE (clone: JES3-
9D7) for regulatory T cells. Thereafter, cells were washed twice and re-suspended 
in fix-perm buffer (eBioscience). To avoid unspecific binding, Fc block 
(eBioscience) was used and for spectral overlap correction, fluorescence 
compensation was done using UltraComp ebeads (eBioscience). Data were 
acquired and analyzed on a FACS Canto flow cytometer (BD Biosciences). The 
gating strategy is depicted in Figure 2.1.    
 Figure 2.1: Gating strategy
(A) lymphocyte gate and (B) 
controls for respectively PE and FITC staining.
 
2.2.8. Cytokine and immunoglobulin 
The levels of cytokines and immunoglobulins from resulting cell culture 
supernatants were measured using the FlowCytomix Mu
the manufactures instructions (eBioscience). For cytokines a human
plex cytokines kit was selected which detected IL
IL-6, IL-5, IL-4, IL-9, IL
immunoglobulins, a human specific 6
IgG2, IgG3, IgG4, IgA and IgM
Measurements were determined using the BD FACS Canto
Biosciences). 
2.2.9. In vitro co-culture
2.2.9.1. Onchocerca volvulus
individuals 
To study levels of immune responsiveness to 
antigen, isolated PBMCs from EN, GEO and HO individuals were cultured in RPMI 
1640 medium supplemented with 10% FCS, penicillin (100µg/ml), Streptomycin 
(100µg/ml), gentamycin (50µg/ml) and 5ml L
analysis, 1x105 PBMCs were plated in 96 round bottomed well plates (U
Greiner Bio-one) and either left unstimulated for spontaneous background cytokine 
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and immunoglobulin secretions or stimulated with either OvAg (20µg/ml) or 
αCD3/αCD28 beads (40,000beads/well, Invitrogen). Samples were cultured in 
duplicate for 7 days to assess cytokine secretion and in unicate for 14 days for 
immunoglobulin analysis. Supernatants were pooled for cytokines analysis.  
2.2.9.2. In vitro modulation of Th17 cell generation by OvAg assay 
To investigate the modulation of Th17 cells development and differentiation by 
OvAg, isolated PBMCs from healthy donors were plated at a concentration of 
2x105 cells/well. These cells were then stimulated with αCD3/αCD28 (20,000 
beads/well were use for this experiment) in the presence of a chemokine cocktail 
(CC: IL-6, 10ng/ml and IL-1β, 5ng/ml) or both the CC and OvAg (12.5µg/ml). Cells 
were cultured for 7 days at 37°C under 5% CO2. 
In order to assess the soluble factors underlining the observed modulatory effect, 
PBMCs were further cultured and activated with αCD3/αCD28 in combination with 
either (i) the CC or (ii) the CC in the presence of rhIL-4, rhIL-13 and rhIL-10 or (iii) 
the CC and OvAg in the presence or absence of neutralizing antibodies for anti-
hIL-4, anti-hIL-13 and anti-hIL-10. Cells were incubated for 7 days under the same 
conditions. 
To investigate cellular mechanisms that are involved in the suppressive effect of 
OvAg,  1x105 CD4+ T cells were cultured alone or in co-culture with either 1x105 B 
cells or 1x105 monocytes per well. T cells were then activated with αCD3/αCD28 
in the presence or absence of the CC. After 7 days of culture, supernatants were 
removed and the cytokine content was measured by enzyme-linked 
immunosorbent assay (ELISA, as described in section 2.2.10.1). 
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2.2.9.3. In vitro study of the shift of GEO phenotype to HO phenotype 
To investigate the potential transformation of a GEO phenotype into a HO 
phenotype, PBMCs from EN and GEO individuals were stimulated with C12-iE-
DAP (PGN-like molecule, 100ng/ml) a NOD1 ligand, ODN 2006 (TLR9 ligand, 
1µM), LPS (TLR4 ligand, 10ng/ml) and Muramyl dipeptide (10µg/ml) a NOD2 
ligand for 7 days. To assess the soluble factors involved in this transformation, 
cells from EN and GEO were left unstimulated or stimulated with αCD3/αCD28 in 
the presence or absence of recombinant human IL-6 and IL-1β (CC). The resulting 
supernatant was then analysed for the presence if IL-17A, IFN-γ-, IL-4 and IL-10 by 
Flowcytomix multiplex assay as described in section 2.2.8. 
2.2.10. Proteins and molecular biology assay 
2.2.10.1. Enzyme-Linked Immunosorbent Assay (ELISA) 
Cytokines in cell culture supernatants were quantified using ELISA. Cytokines 
such as IL-17A, IL-4, IL-10, IL-13 and IFN-γ were measured from the Th17 cells 
modulation experiments and levels of IL-6, TNF-α and IL-10 in the plasticity Treg-
Th17 experiments. Briefly, after diluting the specific capture antibody (1:250) in 
coating buffer (eBioscience), ELISA plates were coated (50µl/well) with capture 
antibody and incubated overnight at 4°C. After 5 washing steps (wash buffer 
appendix), plates were blocked with assay diluents (eBioscience) 50µl/well, for an 
hour at room temperature. Thereafter, plates were washed as previously stated 
and standards and samples were added (50µl/well) and incubated overnight at 
4°C. Secondary biotinylated antibodies (Detection Antibody) were diluted 1:250 
and added to the plates for 1hr at room temperature. Following a further 5 times 
washing, 50 µl/well of streptavidin-peroxidase, diluted (1:250), was added to the 
plates and incubated in darkness at room temperature for 30 minutes. After, plates 
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were washed a final 7 times, 50µl/well of Tetramethybenzidine (TMB, eBioscience) 
substrate was added. Lastly, to stop the reaction 30µl/well of 2NH2SO4 was added. 
Plates were measured at 450nm using a plate reader SpectraMAX 340 Pc 
(Molecular Devices, Ismning, Germany). Data were analyzed with SoftMax Pro 5.0 
software (Molecular Devices). 
2.2.10.2. BradFord protein assay 
To measure the protein concentration of OvAg extract a Bradford protein assay 
was performed as described by the manufacturer’s protocol. In brief, serial 
dilutions of bovine serum albumin (BSA) was performed and used as standards 
against the samples (OvAg). Another serial dilution of the samples was done in 
PBS. 300µl per well of Coomassie blue G (Cytoscelecton, Denver, USA) reagent 
was distributed in duplicate in an ELISA plate and 3µl of diluted samples and 
standard were added accordingly. The protein concentration was quantified at 595 
nm using a plate reader SpectraMAX 340 Pc (Molecular Devices). 
2.2.10.3. RNA Isolation, Reverse Transcription and Real Time PCR 
(qPCR) array 
To investigate in depth the differences between GEO and HO, 84 genes were 
screened by PCR Array using the RT2SYBR Green Mastermix kit (Qiagen, Hilden, 
Germany) and RT2 Profiler PCR Array Human Th17 for autoimmunity and 
inflammation kit (Qiagen) according to the manufacturer's protocol. This array 
profiles genes related to:  i) Surface Molecules: CD28, CD34, CD4, CD8A, ICAM1, 
ICOS, TLR4, ii) Chemokines: CCL1 (I-309), CCL2 (MCP-1), CCL20 (MIP-3A), 
CCL22 (MDC), CCL7 (MCP-3), CX3CL1, CXCL1, CXCL12 (SDF1), CXCL2, 
CXCL5 (ENA78/LIX), CXCL6 (GCP-2), IL8, MMP3, MMP9, iii) Cytokines: CSF2 
(GM-CSF), CSF3 (GCSF), IFNγ, IL10, IL12B, IL13, IL15, IL17A, IL17C, IL17D, 
IL17F, IL18, IL1B, IL2, IL21, IL22, IL23A, IL25 (IL17E), IL27, IL3, IL4, IL5, IL6, IL9, 
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TGFB1, TNF, iv) Cytokine Receptors: CCR2, CCR4, CCR6, IL1R1, IL12RB1, 
IL12RB2, IL17RA, IL17RB, IL17RC, IL17RE, IL23R, IL6R, IL7R and v) Signaling 
Pathway Molecules and Transcriptional Factors: CD40LG (TNFSF5), CEBPB, 
CLEC7A (Dectin-1), FOXP3, GATA3, IRF4, ISG20, JAK1, JAK2, NFATC2, 
NFKB1, RORA, RORC, RUNX1 (AML1), S1PR1, SOCS1, SOCS3, STAT3, 
STAT4, STAT5A, STAT6, SYK, TBX21, TRAF6. In brief, PBMCs from GEO, EN 
and HO individuals were stimulated with αCD3/αCD28 (Ratio beads-to-cell 1:10) 
for 3 hours at 37°C. Thereafter RNA was extracted using Trizol (Invitrogen). DNA 
was digested using the DNA-free kit (Invitrogen) and the concentration and the 
purity of RNA was determined using the NanoDrop 1000 (Peqlab, Erlangen, 
Germany). Extracted RNA was reverse transcribed using the Qiagen Master mix 
(Qiagen,) by adding 0.5µg of RNA and incubating in the Primus Thermocycler 
(MWG-Biotech, Ebersberg, Germany). Amplification was performed on the 
RotorGene 6000 (Corbett Research, Sydney, Australia). Data were analyzed by 
RT2 profiler PCR Array data analysis 3.5 software (Qiagen).  
2.2.11. Statistical analysis 
Statistical analyses were performed using the software PRISM 5.02 (GraphPad 
Software, Inc., La Jolla, USA). Depending on the parameter distribution of the data 
sets, statistical differences were observed using either an ANOVA or Kruskal-
Wallis-test and, if significant, followed by Student's t test or Mann-Whitney–U test 
for a further comparison of two groups. P-values of 0.05 or less were considered 
significant * p<0, 05, ** p<0, 01 and *** p<0, 001. 
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3. Results 
3.1. Population characteristics 
Onchocerca volvulus-infected individuals within this study cohort were diagnosed 
as described in section 2.2.2. Individuals were then further characterized as 
having either generalized onchocerciasis (GEO, n=28) or hyperreactive 
onchocerciasis (HO, n=6). For comparison, infection-free volunteers, residing in 
the same area were recruited as well (EN, n=28). Table 1 presents the 
characteristics of the study population. The mean age was similar in each study 
group (38.96 vs. 38.66 in GEO and HO respectively). The number of male and 
female participants in the HO group was equal and in the GEO and EN groups 
they were comparable. Microfilariae load, the number of nodules and sites of 
infection were only described for the GEO group. HO individuals presented neither 
microfilariae nor nodules. HO individuals presented either depigmentation/leopard 
skin condition (n=3); acute papular onchodermatitis (n=1) or sowda (n=2). The 
immunological determinant which drives the differences between GEO and HO 
needs further investigations. Therefore, in the following section, immune cell 
profiles in GEO and HO versus EN was characterized. 
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Table 1: Characteristics of the study population 
 GEO 
(n=28) 
HO 
(n=6) 
Endemic normals  
(n=28) 
Age (mean/range) 38.96 (19-55) 38.66 (24-55) 38.26 (18-55) 
Gender (F/M) 11/17 3/3 15/13 
Mf load mg/skin 8.99 (0.1-86.10) 0 - 
Number of nodules 1.97(1-9) 0  
Number of sites 1.36(1-6) 0  
Dermatitis - Yes  
Co-infections 0 0 0 
Age: mean (range); Gender: Number of female/male participants; Mf load mg/skin count: mean 
(range); Number of nodules: mean (range); Number of sites: mean (range), Co-infection: Number 
of co-infected. GEO: Generalized onchocerciasis; HO: Hyperreactive onchocerciasis. 
3.2. Differing immune cell profiling in Onchocerca volvulus-infected 
individuals 
3.2.1. Higher frequencies of monocytes and memory helper T cells 
To distinguish whether differences in immune cell profiles occur in individuals 
presenting the polar forms of onchocerciasis, the frequency of NK cells, NK T 
cells, monocytes, B cells, T helper cells and CD8+ T cells from PBMCs were 
analyzed. With regards to the latter population, individuals with GEO had 
significantly less CD8+ T cells when compared to EN (Figure 3.1A). NK and NKT 
cell populations were determined using combinations of anti-CD3, anti-CD16 and 
anti-CD56 (Figure 3.1B-E).  
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Figure 3.1: Evidence of reduced frequencies of monocytes and memory helper T 
cells in individuals with GEO onchocerciasis.  
Isolated PBMCs from EN (n=16) and individuals presenting either generalized (GEO, n=16) or 
hyperreactive onchocerciasis (HO, n=6) were stained with a combination of antibodies to determine 
the frequencies of CD8
+
 T cells (A); NK cells [CD3
-
CD16
bright
CD56
dim
 (B) and CD3
-
CD16
dim
CD56
bright
 (C)]; NKT cells [CD3
+
CD16
+
 (D) and CD3
+
CD56
+
 (E)]; CD19
+
CD27
+
 memory B 
cells (F); CD14
+
 monocytes (G); memory CD4
+
 T cells (H) and naive CD4
+
 T cells (I). Graphs show 
box whiskers tukey with outliers from EN n=10, GEO n=10 and HO n=6. Asterisks show statistical 
differences (Kruskal-Wallis and Mann Whitney test) between the groups indicated by the brackets 
(*p<0.05, **p<0.01, ***p<0.001). 
 
When compared to levels in EN, both CD16brightCD56dim and CD16dimCD56bright NK 
populations were significantly lower in GEO and HO individuals but no differences 
could be observed between GEO and HO groups (Figure 3.1B and C 
respectively). CD3+CD16+ but not CD3+CD56+ NKT cells were also lower in GEO 
but not HO individuals (Figure 3.1D and E). Whereas no differences could be 
observed in the frequency of memory B cells (Figure 3.1F), significantly elevated 
numbers of monocytes (CD14+ cells) were identified in HO individuals (Figure 
3.1G). This phenotype was also observed upon staining for memory 
CD4+CD45RO+ T cell populations ( Figure 3.1H) and interestingly, levels of naive 
CD4+CD45RA+T cells in this group were significantly lower than in individuals with 
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GEO or EN (Figure 3.1I). This suggests an active immune response associated 
with helper T cell activity in HO individuals. 
3.2.2.  Hyperreactive onchocerciasis is associated with elevated CD4+IL-
17+A and CD4+IL-4+-producing T cells  
The increased monocyte frequencies in HO individuals in the previous section 
could be explained by an increased antigen presentation requirement. This could 
have led to the elevated memory helper T cells seen in this group (Figure 3.1H). 
CD4+ T cells upon activation by APC can differentiate into effector Th1, Th2 and 
Th17 cells and iTreg [103, 104]. Therefore, we next determined the frequency of 
CD4+ T cells producing IFN-γ, IL-4, IL-17A and IL-10 through intracellular staining 
after activating PBMCs with PMA, Ionomycin, Brefeldin A and Monensin (as 
described in section 2.2.6.2 ). As shown in Figure 3.2A, the frequency of CD4+IFN-
γ
+ T cells was significantly higher in EN than in either O. volvulus-infected group. 
Moreover, CD4+ T cells from GEO individuals produced significantly higher 
amounts of IFN-γ than cells from HO individuals (Figure 3.2A). In contrast, 
individuals with GEO or HO displayed significantly elevated frequencies of IL-4-
secreting CD4+ T cells when compared to EN groups (Figure 3.2B). Interestingly, 
cells from HO individuals produced more IL-4 than cells from GEO persons (Figure 
3.2B), a phenotype further reflected by CD4+ T cells secreting IL-17A (Figure 
3.2C). Whereas IL-17A producing CD4+ T cells appeared to be a unique 
characteristic in individuals presenting the hyperreactive form of the disease, those 
with GEO had a dominant IL-10 producing phenotype (Figure 3.2D). Figure 3.3 
shows representative flow cytometry data depicting the expression in percentages 
of Th2 and Th17  cytokine release in EN, GEO and HO individuals. 
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Figure 3.2: Hyperreactive individuals exhibit a dominant IL-4 and IL-17 phenotype. 
Isolated PBMCs from EN (n=10) and O. volvulus-infected individuals presenting either GEO (n= 
10) or HO (n=6) were activated with a stimulation cocktail (PMA, Ionomycin, Brefeldin A and 
Monensin) for 6 hours. Thereafter, cells were harvested and stained with an anti-CD4 antibody and 
after fixation and permeabilization with anti-human antibodies specific for IFN-γ (A), IL-4 (B), IL-17A 
(C) and IL-10 (D). Intracellular cytokine expression was determined on the CD4
+
 T cell population 
by flow cytometry. Graphs show percentages as box whiskers with outliers. Asterisks show 
statistical differences (Kruskal-Wallis and Mann Whitney test) between the groups indicated by the 
brackets (*p<0.05, **p<0.01, ***p<0.001). 
 Figure 3.3: Expression profiles in percentage of different Th2 and Th17   cell
cytokine in PBMCs from  EN, GEO and HO individuals.
PBMCs from EN (n=10) and O. volvulus
(n=6) were activated with a stimulation cocktail (PMA, Ionomycin, Brefeldin A and Monensin) for 6 
hours. Thereafter, cells were harvested and stained with an anti
or IL-17A conjugated antibodies. 
representative individual from the EN (left panel), the GEO (middle) and the HO (r
Flow cytometry was performed using a BD FACS Canto I  and analyzed using FACSDiva 5.2 
software.  
 
3.2.3. Higher expression of CD4
hyperreactive individuals
In the above section the c
dominant Th2 and Th17 responses.
with related transcription factors
expression of T-bet, GATA3, RORC2
cytometry. In association with their elevated amounts of IFN
cells (Figure 3.2A), EN had significantly higher numbers of CD4
when compared to hyperreactive onchocerciasis individuals (
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Strikingly, the Treg associated transcription factor Foxp3 was prominently 
expressed by CD4+ T cells from hyperreactive individuals, even when compared to 
individuals with GEO (Figure 3.4B).  
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Figure 3.4: Hyperreactive onchocerciasis individuals present higher frequencies of 
CD4+Foxp3+ but not CD4+CD25hiFoxp3+ T cells. 
PBMCs from EN and O. volvulus-infected GEO or HO individuals were activated with a cell 
stimulation cocktail (PMA, Ionomycin, Brefeldin A and Monensin) for 6 hours. Thereafter, cells were 
harvested and stained for CD4 and the transcription factors, T-bet (A), Foxp3 (B,D), RORC2(E) 
and GATA3(F). PBMCs fractions were then further stained with CD25 to assess the numbers of 
CD4
+
CD25
hi
 (C) and CD4
+
CD25
hi
Foxp3
+
 (D) T cells in each individual (EN n=16, GEO n= 16, HO 
n= 6). Cell population frequencies were determined via flow cytometry. Graphs show percentages 
as box whiskers with outliers. Asterisks show statistical differences (Kruskal-Wallis and Mann 
Whitney test) between the groups indicated by the brackets (*p<0.05, **p<0.01, ***p<0.001). 
 
To elucidate on this unexpected expression of Foxp3 in HO individuals, we 
expanded our profile panel to include CD4+CD25hiFoxp3+ T cells using the above 
depicted gating strategies (Figure 2.1 and Figure 3.3). Interestingly, the inclusion 
of CD25hi cells dramatically changed the profile of CD4+ T cells from HO 
individuals since both CD4+CD25hi (Figure 3.4C) and CD4+CD25hiFoxp3+ (Figure 
3.4D) T cell subsets were higher in GEO individuals. More interestingly, the 
expression of RORC2 (Figure 3.4E) and GATA3 (Figure 3.4F) correlated with IL-
17A and IL-4 profiles and were higher in HO individuals compared to EN and GEO 
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groups. Moreover, expression levels of CD4+GATA3+ T cells were increased in 
GEO compared to EN participants (Figure 3.4F). These data indicate a correlation 
between T cell transcription factors and cytokine induction in onchocerciasis 
patients and confirm that Th2 and Th17 are characteristic of hyperreactive 
onchocerciasis. 
3.2.4. Increased ratios of Th17/Treg in hyperreactive onchocerciasis 
individuals 
The combination of Th2 and Th17 responses characterized individuals with 
hyperreactive onchocerciasis. In order to evaluate the dominant T helper 
response, ratios amongst the different T helper cytokines and transcription factors 
were assessed. These data revealed that there were significant increases in the 
ratio of CD4+IL-4+ vs CD4+IFN-γ+ in HO compared to EN and GEO (Figure 3.5A). 
Moreover, this ratio was increased in GEO compared to EN (Figure 3.5A) 
confirming the prominent Th1 response in EN.  
Additionally, the ratio in CD4+IL-17A+ vs CD4+IFN-γ+ (Figure 3.5B) was increased 
in HO compared to EN and GEO. More interestingly, the ratios CD4+CD25hiFoxp3+ 
vs CD4+GATA3+ (Figure 3.5C), CD4+RORC2+ vs CD4+CD25hiFoxp3+ (Figure 
3.5D) and CD4+IL-17A+ vs CD4+IL-10+ (Figure 3.5E) were increased in HO 
compared to EN and GEO individuals; confirming the dominant Th2 and Th17 
responses in HO. The ratios of CD4+IL-10+ vs CD4+IFN-γ+ (Figure 3.5F) and 
CD4+IL-10+ vs CD4+IL-4+ (Figure 3.5G) were increased in GEO compared to the 
other groups confirming the dominant regulatory response in GEO individuals. 
Moreover the ratio CD4+RORC2+ vs CD4+T bet+ was higher in HO compared to 
either EN or GEO(Figure3.5H). These results suggest that the balance of 
Th17/Treg determine the pathological outcomes in hyperreactive onchocerciasis. 
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Figure 3.5: Elevated ratios of CD4+IL-17A+ vs CD4+IL-10+ in HO individuals. 
Following the assessment of cytokine levels in CD4
+
 T cells in all three study groups via flow 
cytometry ratios amongst the different profiles were determined. (A) CD4
+
IL-4
+
 vs CD4+IFN-ϒ
+
, (B) 
CD4
+
IL-17A
+
 vs CD4
+
IFN-ϒ
+
, (C) CD4
+
RORC2
+
 vs CD4
+
GATA3
+
, (D) CD4
+
RORC2
+
 vs 
CD4
+
CD25
hi
Foxp3
+
, (E) CD4
+
IL-17A
+
 vs CD4
+
IL-10
+
, (F) CD4
+
IL10
+
 vs CD4
+
IFN-ϒ
+
, (G) CD4
+
IL-
10
+
 vs CD4
+
IL-4
+
 and (H) CD4
+
RORC2
+
CD4
+
T bet
+
. Each dot represents the ratio ±SD of these 
combinations. Data of each ratio constellation were compared using Kruskal-Wallis and Mann-
Whitney test and significant differences are given as *p<0.05, **p<0.01 and ***p<0.001. 
 
3.2.5. Up-regulation of markers for Th2 and Th17 gene expression in 
hyperreactive onchocerciasis 
To further investigate the association of hyperresponsiveness and elevated IL-
17A- and IL-4-secreting CD4+ T cells, RT-qPCR was performed using RT2 Profiler 
PCR Array Human Th17 kit . This kit profiles the expression of 84 genes related to 
the Th17 Regulatory Network such us i) Surface Molecules: CD28, CD34, CD4, 
CD8A, ICAM1, ICOS, TLR4, ii) Chemokines: CCL1 (I-309), CCL2 (MCP-1), 
CCL20 (MIP-3A), CCL22 (MDC), CCL7 (MCP-3), CX3CL1, CXCL1, CXCL12 
(SDF1), CXCL2, CXCL5 (ENA78/LIX), CXCL6 (GCP-2), IL8, MMP3, MMP9, iii) 
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Cytokines: CSF2 (GM-CSF), CSF3 (GCSF), IFNγ, IL10, IL12B, IL13, IL15, IL17A, 
IL17C, IL17D, IL17F, IL18, IL1B, IL2, IL21, IL22, IL23A, IL25 (IL17E), IL27, IL3, 
IL4, IL5, IL6, IL9, TGFB1, TNF, iv) Cytokine Receptors: CCR2, CCR4, CCR6, 
IL1R1, IL12RB1, IL12RB2, IL17RA, IL17RB, IL17RC, IL17RE, IL23R, IL6R, IL7R 
and v) Signaling Pathway Molecules and Transcriptional Factors: CD40LG 
(TNFSF5), CEBPB, CLEC7A (Dectin-1), FOXP3, GATA3, IRF4, ISG20, JAK1, 
JAK2, NFATC2, NFKB1, RORA, RORC, RUNX1 (AML1), S1PR1, SOCS1, 
SOCS3, STAT3, STAT4, STAT5A, STAT6, SYK, TBX21, TRAF6. 
As described in section 2.2.10.3.  RNA was isolated from PBMCs of HO (n=2) and 
GEO (n=2) individuals. Extracted RNA was reverse transcribed using Qiagen 
Master mix  and incubated in the Primus Thermocycler. Amplification was 
performed on the RotorGene 6000. Data were analyzed using Qiagen free PCR 
Array Data Analysis Software. A total of 46 genes were over-expressed, 18 genes 
were down-regulated and 20 genes were unchanged (Figure 3.6A). In correlation 
with the higher amounts of Th17 cells, IL-17 gene family members such as IL17A, 
IL17C, IL17D and IL17F were all up-regulated in cells from HO individuals (Figure 
3.6C). Furthermore, this trend was observed with Th17-related transcription factor 
RORC and signalling pathway molecule STAT3 genes (Figure 3.6C). The genes of 
cytokines known to be required for the induction of Th17 cells such as IL-6, IL-1β, 
TGF-β1, IL-21 and IL-23A [131, 132] were also highly up-regulated in HO persons 
(Figure 3.6D). In addition the IL22 gene, another Th17 related cytokine was up-
regulated in hyperreactive individuals (Figure 3.6D). Correlating with the 
unexpected observation that CD4+Foxp+ cells were higher in HO compared to 
GEO (Figure 3.2), Foxp3 gene expression followed the same trend (Figure 3.6A. 
In contrast, suppressor of cytokine signaling protein 3 gene (SOCS3) was 
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downregulated in HO (Figure 3.6A. With regards to Th2-related genes, here the 
IL13 gene presented the strongest fold increase and correlated to the elevated 
gene expression of GATA3 and STAT6 (Figure 3.6E). More interestingly, in 
correlation with elevated Treg responses observed in GEO compared to HO, Treg-
related genes CCL1 and IL-7R were down-regulated in HO compared to GEO 
(Figure 3.6A. Cytokines profiling in Figure 3.2 showed elevated CD4+IFN-γ+ cells in 
GEO compared to HO. In concordance with this data, Th1-related genes such as 
IL-12B and IL-12RB genes were also up-regulated in GEO compared to HO 
individuals (Figure 3.6A). Overall, these findings confirm and correlate with the T 
helper cell profiles observed in section 3.2.2. 
 PBMCs were stimulated with 
and transcribed into cDNA. Thereafter, PCR Arrays were performed using the RT
Array Human Th17 kit. Data were analyzed using Qiagen free PCR Array Data Analysis Software. 
(A), A heat map provides a graphical representation of fold regulation expression data between the 
two groups (GEO Vs HO). (B), Corresponding gene table. (C
SEM increase in the indicated genes between four age
HO forms of infection. 
Figure 3.6: Up-regulation of Th2 and Th17 gene expression in HO 
individuals. 
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3.3. Onchocerca volvulus antigen-specific responses in infected individuals 
Peripheral mononuclear cell profiling in section (3.2) using FACS analysis and RT-
qPCR has shown that hyperreactive onchocerciasis individuals exhibited higher 
levels of Th2 and Th17 responses, whereas EN and GEO depicted increased 
levels of Th1 and Treg responses respectively. Both techniques FACS and qPCR 
could not tell if these different responses were filarial-specific or not. Therefore, in 
this section it was further investigated using in vitro cell cultures the specificity of 
these responses. 
3.3.1. Elevated OvAg-specific Th1 and Th2 responses in endemic normals 
and hyperreactive onchocerciasis individuals respectively 
In the previous sections (3.2.2 and 3.2.3), elevated Th1 and Th2 profiles were 
revealed in HO individuals using flow cytometry. Since helminth infections have 
been shown to induce Th and Th2 type response in putative immunity and infected 
individuals respectively, in this section, it was assessed whether these responses 
were also reflected in cell cultures following activation with an antigen preparation 
derived from Onchocerca volvulus adult worms (OvAg). Interestingly, when 
compared to either EN or GEO groups, OvAg-stimulated (20µg/ml) PBMCs from 
HO individuals made significantly higher amounts of IL-5 (Figure 3.7A). Upon TCR 
activation, no difference was seen between the groups but increased induction of 
this cytokine was observed in EN, GEO and HO compared to their control cultures 
(Figure 3.7B). Another Th2 cytokines, IL-13, produced a similar pattern to IL-5 
following OvAg stimulation (Figure 3.7C). Interestingly, not only the activation with 
αCD3/αCD28 reflected increased levels of IL-13 in each group compared to its 
control but also this was statistically significant in HO compared to EN and GEO. 
(Figure 3.7D). This induction was similar to those observed in IFN-γ (Th1 cytokine) 
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levels after TCR activation (Figure 3.7E). Base line secretion of IFN-γ was higher 
in EN compared to HO (Figure 3.7F). Regarding IL-10 secretion, no differences 
were seen upon OvAg stimulation (Figure 3.7G) but a higher induction was 
observed in both GEO and HO compared to their controls after TCR activation 
(Figure 3.7H). 
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Figure 3.7: Hyperreactive individuals present stronger filarial-specific Th2 
responses in vitro. 
Isolated PBMCs (1x10
5
/well) from EN (n=16) and O. volvulus-infected GEO (n= 16) or HO (n=6) 
individuals were left either unstimulated or activated with an O. volvulus antigen extract (OvAg, 
20µg/ml) and αCD3/αCD28 (αCD3, 40,000beads/well ) for 7 days. Thereafter, levels of IL-5 (A, B), 
IL-13 (C, D), and IFN-γ (E, F) and  IL-10 (G, H) were measured in the culture supernatants using a 
FlowCytomix™ Multiplex kit via flow cytometry. Graphs show data as box whiskers with outliers. 
Asterisks show statistical differences (Kruskal-Wallis and Mann Whitney test) between the groups 
indicated by the brackets (*p<0.05, **p<0.01, ***p<0.001).  
 
3.3.2. Increased Th17-related cytokines after OvAg stimulation 
Th17 cell markers and their related cytokines were observed to be associated with 
HO using FACS and qPCR array ( section 3.2.4, 3.2.5 and 3.2.6). As mentioned 
above, the induction of Th17 cells has been shown to require IL-6, IL-1β, TGF-β 
 43  
 
and IL-23 [133], therefore the levels of Th17-related cytokines following activation 
with either OvAg or αCD3/αCD28 were also measured. Interestingly, basal levels 
of IL-17A production from cell cultures of HO individuals were equal to those 
stimulated with OvAg and the amount was significantly higher than basal levels of 
cells from the GEO group (Figure 3.8A). Upon activation with αCD3/αCD28 
however, cells from HO individuals presented significantly higher levels of IL-17A 
when compared to both EN and GEO groups (Figure 3.8B). Furthermore, Th17 
cells in each group were activated upon co-culture with αCD3/αCD28 compared to 
their unstimulated controls (Figure 3.8B). This pattern from cells of HO individuals 
was also reflected with IL-6 following both OvAg (Figure 3.8C) and αCD3/αCD28 
(Figure 3.8D). In addition, background induction of IL-6 was higher in HO 
compared to GEO and EN (Figure 3.8C-D). As with IL-17A, no significant 
differences in the levels of IL-22 was seen (Figure 3.8E). However, TCR activation 
showed higher induction of IL-22 in each group compared to its control and also 
there was a significant increase of IL-22 in HO compared to both EN and GEO 
(Figure 3.8F). The secretion pattern of IL-1β following stimulation with OvAg 
(Figure 3.8G) or αCD3/αCD28 (Figure 3.8H) was similar to those of IL-22. Thus, 
although the overall OvAg-specific Th17-related responses were not highly 
significant in hyperreactive individuals, they did present a strong enhanced Th17 
profile upon αCD3/αCD28 activation indicating a biased inflammatory profile.  
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Figure 3.8: Elevated IL-17A and Th17-related cytokines in cell cultures from HO 
individuals following TCR activation.  
Isolated PBMCs (1x10
5
/well) from EN (n=16) and O. volvulus-infected GEO (n= 16) or HO (n=6) 
individuals were left either unstimulated or activated with αCD3/αCD28 (αCD3, 40,000beads/well) 
for 7 days. Thereafter, levels of IL-17A (A, B), IL-6 (C, D), IL-22 (E, F) and IL-1β (G, H) were 
measured in the culture supernatants using a FlowCytomix™ Multiplex kit via flow cytometry. 
Graphs show data as box whiskers with outliers. Asterisks show statistical differences (Kruskal-
Wallis and Mann Whitney test) between the groups indicated by the brackets (*p<0.05, **p<0.01, 
***p<0.001). 
 
3.3.3. Increased Th9 OvAg-specific responses in hyperreactive 
onchocerciasis 
Although the exact function of Th9 has yet to be completely determined, functions 
in immunity against helminth infections and/or the promotion of inflammatory 
diseases have been suggested [134]. Therefore, levels of Th9 were also 
investigated in human Onchocerca volvulus-infected patients. The secretion of IL-
9 was significantly induced in cultures from HO individuals after OvAg stimulation 
when compared to either EN or GEO (Figure 3.9A). In addition, activation of 
PBMCs from EN with OvAg showed significantly increased amounts of IL-9 
compared to GEO (Figure 3.9A). Moreover, whereas no detectable amounts were 
observed in GEO after OvAg activation, HO and EN exhibited increased IL-9 
compared to controls (Figure 3.9A-B).  However no significant differences in the 
induction of IL-9 was observed among the groups upon TCR activation with 
αCD3/αCD28 (Figure 3.9B) but there was an activation of Th9 cells by 
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αCD3/αCD28 stimulation in each group compared to its control (Figure 3.9B). This 
could suggest that Th9 cells are also implicated in the pathology of human 
onchocerciasis.  
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Figure 3.9: Strong induction of Ov-specific IL-9 secretion in cell cultures from 
hyperreactive individuals.   
Isolated PBMCs (1x10
5
/well) from EN (n=16) and O. volvulus-infected GEO (n= 16) or HO (n=6) 
individuals were left either unstimulated (Cont.) or activated with either an O. volvulus antigen 
extract (OvAg, 20µg/ml) or αCD3/αCD28 (αCD3, 40,000 beads/well) for 7 days. Thereafter, levels 
of IL-9 (A and B) were measured in the culture supernatants using a FlowCytomix™ Multiplex 
assay. Graphs show data as box whiskers tukey with outliers. Asterisks show statistical differences 
(Kruskal-Wallis and Mann Whitney test) between the groups  (*p<0.05, **p<0.01, ***p<0.001). 
 
3.3.4. Elevated antigen-specific TNF-α induction but not IL-12 and IL-2 in 
hyperreactive onchocerciasis 
In figures 3.2A and 3.7E, the presented data shows an increased Th1 response in 
EN individuals by both flow cytometry and OvAg-stimulation. Expanding on those 
findings, levels of Th1-related cytokines, TNF-α, IL-2 and IL-12, were measured in 
cell cultures of PBMCs following activation with either OvAg or αCD3/αCD28. The 
results indicated an increase in TNF-α secretion in cell cultures from HO 
individuals compared to its control and to data from GEO groups (Figure 3.10A). 
The stimulation with αCD3/αCD28 induced a higher secretion of TNF-α in HO 
compared to both EN and GEO groups (Figure 3.10B). However, TNF-α levels 
were higher in EN, GEO and HO compared to their control (Figure 3.10B). 
Whereas IL-2 was not significantly induced by OvAg in cells from each group 
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(Figure 3.10C), TCR activation showed a significantly higher IL-2 secretion in HO 
compared to EN and GEO groups (Figure 3.10D). Low levels of IL-12p70 were 
detectable (Figure 3.10E-F). This suggests that OvAg-specific Th1 responsiveness 
in HO individuals is restricted to the production of TNF-α but not other Th1-related 
cytokines. 
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Figure 3.10: PBMCs from hyperreactive onchocerciasis individuals present elevated 
TNF-α secretion upon culture with Ov-antigen.  
Isolated PBMCs (1x10
5
/well) from EN (n=16) and O. volvulus -nfected GEO (n= 16) or HO (n=6) 
individuals were left either unstimulated (Cont.) or activated with either O. volvulus antigen extract 
(OvAg, 20µg/ml) or αCD3/αCD28 (αCD3, 40,000 beads/well) for 7 days. Thereafter, levels of TNF-
α (A and B) and IL-2 (C-D) and IL-12p70 (E-F) were measured in the culture supernatants using a 
FlowCytomix™ Multiplex assay. Graphs show data as box whiskers with outliers. Asterisks show 
statistical differences (Kruskal-Wallis and Mann Whitney test) between the groups indicated by the 
brackets (*p<0.05, **p<0.01, ***p<0.001). 
 
3.4.   T helper cell profiling upon OvAg stimulation 
In the previous section, the secretion of cytokines in the supernatants after PBMCs 
stimulation with antigen was investigated. The source of these cytokines could be 
a number of cells types within the PBMCs fraction. In addition, the cytokine profile 
from cell culture supernatants did not follow the trend observed after direct FACS 
analysis of cultured PBMCs. For instance HO individuals showed strong IL-17A 
responses after FACS but no differences were seen after OvAg stimulation. 
Therefore, we next characterized OvAg-stimulated cells per FACS analysis.   
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3.4.1.  Higher antigen-specific CD4+T-bet+ but not CD4+IFN-γ+ T cells in HO 
individuals 
In the above section (3.3.1.), peripheral blood mononuclear cells from EN showed 
elevated OvAg-specific IFN-γ secretion in the supernatants from EN compared to 
HO.  To further investigate whether this IFN-γ induction was from Th1 cells, 
PBMCs from EN, GEO and HO were cultured alone (Cont.) or activated with either 
αCD3/αCD28 (αCD3.) or OvAg. After 7 days culture, cells were harvested and 
following PMA/Ionomycin activation, Th1 cell marker levels were determined by  
FACS analysis. Base line expression of T-bet in CD4 population was increased in 
HO compared to GEO and EN (Figure 3.11A-B). Furthermore, the HO group 
showed increased levels of CD4+T-bet+ T cells upon stimulation with OvAg (Figure 
3.11A) and αCD3/αCD28 (Figure 3.11B) compared to other groups. However, no 
difference in CD4+IFN-γ+ T cells could be observed after co-culture with OvAg 
(Figure 3.11C). In contrast, TCR activation with αCD3/αCD28 (Figure 3.11D) 
showed increased expression of IFN-γ+ CD4 T cells in GEO and HO compared to 
their non-stimulated control samples.  The data did not confirm  cytokine profiles 
from cell culture supernatants. This suggests that IFN-γ observed in cell culture 
supernatants may come from other cells in PBMCs.  
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Figure 3.11: Elevated Onchocerca volvulus-specific CD4+T-bet+ but not CD4+IFN-γ+ 
cells in HO patients.  
Peripheral blood mononuclear cells (1x10
5
/well) from endemic normal EN(n=16), GEO(n=16) and 
HO(n=6) individuals were left unstimulated (Cont.) or stimulated with αCD3/αCD28 (αCD3. 40,000 
beads/well ) or Onchocerca volvulus-antigen (OvAg, 20µg/ml ). After 7 days of culture, cells were 
harvested and stimulated with a cell stimulation cocktail containing PMA, Ionomycin, Brefeldin A 
and Monensin for 6 hours and then stained for the Th1 transcription factor T-bet and cytokine IFN-
γ. Each dot represents the mean percentage± SD of CD4
+
T-bet
+
 and CD4
+
IFN-γ
+
  expression. Data 
of each group were compared using Kruskal-Wallis and Mann-Whitney test and significant 
differences are given as *p< 0. 05, **p<0.01 and ***p<0.001. 
 
3.4.2. Onchocerca volvulus adult worm antigen induces elevated GATA3 but 
not IL-4 expression in CD4+ T cells from HO individuals 
In section 3.2, it was demonstrated that hyperreactive onchocerciasis individuals 
exhibited an increase Th2 phenotype after FACS analysis and PCR array. This 
phenotype was specific for the parasite since upon OvAg activation, cell culture 
supernatants showed increased Th2 cytokines such as IL-5 and IL-13. Here it was 
aimed to investigate if the release of the these cytokines was from Th2 cells. Of 
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interest, the Th2 cytokine, IL-4 was not detectable in cell culture supernatants 
(data not shown). Therefore, cells from EN, GEO and HO were cultured either in 
medium alone (Cont.) or stimulated with either OvAg or αCD3/αCD28. After 7 
days, cells were harvested and activated with PMA, Ionomycin, Brefeldin A and 
Monensin. After 6 hours, cells were characterized by FACS. The background 
expression of GATA3 was not different amongst the groups (Figure 3.12A-B). 
However, HO individuals exhibited increased CD4+GATA3+ T cells after OvAg 
stimulation compared to GEO and EN (Figure 3.12A).  
Co
nt
.
Ov
Ag
Co
nt
.
Ov
Ag
Co
nt
.
Ov
Ag
0
10
20
30
40
EN
GEO
HO
*
*
*
A
%
C
D
4
+
G
A
T
A
3
+
T
 c
e
ll
s
Co
nt
.
C
D3
.
α C
on
t.
C
D3
.
α C
on
t.
C
D3
.
α
0
10
20
30
EN
GEO
HO
***
***
*
B
%
C
D
4
+
G
A
T
A
3
+
T
 c
e
ll
s
Co
nt
.
Ov
Ag
Co
nt
.
Ov
Ag
Co
nt
.
Ov
Ag
0
10
20
30
40
EN
GEO
HO
*
C
%
C
D
4
+
IL
-4
+
T
 c
e
ll
s
Co
nt
.
CD
3.
α C
on
t.
CD
3.
α C
on
t.
CD
3.
α
0
5
10
15
20
EN
GEO
HO
**
*D
%
C
D
4
+
IL
-4
+
T
 c
e
ll
s
Figure 3.12: Elevated Onchocerca volvulus-specific CD4+GATA3+ but not CD4+IL-4+ 
T cells in HO individuals. 
PBMCs(1x10
5
cell/well) from EN(n=16), GEO(n=16) and HO(n=6) individuals were left unstimulated 
(Cont.) or stimulated with αCD3/αCD28 (αCD3., 40,000 beads/well ) or Onchocerca volvulus-
antigen (OvAg, 20µg/ml ). After 7 days of culture, cells were harvested and stimulated with a cell 
stimulation cocktail containing PMA, Ionomycin, Brefeldin A and Monensin for 6 hours .Thereafter 
cells were stained for the Th2 transcription factor GATA3 and cytokine IL-4. Each dot represents 
the mean percentage ± SD of CD4
+
GATA3
+
 (A and B ) and CD4
+
IL-4
+
 (C and D) T cell populations. 
Data of each group were compared using Kruskal-Wallis and Mann-Whitney test and significant 
differences are given as *p<0. 05 and ***p<0.001. 
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More interestingly, the expression of GATA3 in CD4+ T cell populations did not 
differ from OvAg's trend after TCR activation with αCD3/αCD28 (Figure 3.12B). In 
contrast, background IL-4 expressing CD4+ T cells  was significantly lower in T 
cells from HO individuals when compared to EN and GEO groups (Figure 3.12C-
D). No differences were observed in the levels of IL-4 amongst the groups upon 
OvAg activation (Figure 3.12C). Overall TCR activation decreased IL-4 expression 
in CD4+ T cells compared to non-stimulated control samples and this decrease 
was significant in cultures from EN individuals (Figure 3.12D). This partially 
confirms our previous observations since HO individuals had OvAg-specific Th2 
cytokines (increased IL-5 and IL-13) profiles in cell culture supernatants.  
3.4.3. Elevated Onchocerca volvulus-specific CD4+RORC2+ but not CD4+IL-
17+ cells in HO individuals  
Strong Th17-related markers were observed after FACS analysis and PCR array 
in HO individuals (section 3.2). In contrast, IL-17A measured in cell culture 
supernatants was not different amongst the groups after OvAg stimulation and 
levels were also low. This could be that this cytokine was directly reabsorbed after 
its induction. Therefore, PBMCs from EN, GEO and HO were cultured for 7 days in 
medium alone (Cont.) or stimulated with either αCD3/αCD28 (αCD3) or OvAg. 
Thereafter, cells were harvested and activated with PMA, Ionomycin, Brefeldin A 
and Monensin. After 6 hours, T cells were characterized by FACS. As expected, 
OvAg and αCD3/αCD28 stimulation induced elevated CD4+RORC2+ T cells in HO 
individuals compared to EN and GEO persons (Figure 3.13A-B). Interestingly, 
background expression of RORC2 in CD4+ T cell populations was higher in HO 
compared to EN and GEO (Figure 3.13A-B). TCR activation using αCD3/αCD28 
induced increased expression of CD4+RORC2+ T cells in EN and HO compared to 
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controls (Figure 3.13B). In contrast, the trend of CD4+IL-17A+ T cells did not 
correlate with RORC2 expression neither with OvAg stimulation (Figure 3.13C) nor 
TCR activation (Figure 3.13D). Basal expression of IL-17A was higher in EN and 
GEO compared to HO individuals (Figure 3.13C-D). Interestingly, OvAg 
stimulation induced IL-17A secretion in GEO compared to HO groups (Figure 
3.13C). This data could indicate a negative feedback control of IL-17A induction 
and since cells were pre-stimulated with PMA, this could boost RORC2 expression 
but not the release of IL-17A.  
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Figure 3.13: Elevated Onchocerca volvulus-specific CD4+RORC2+ but not CD4+IL-
17A+ T cells in HO individuals.  
PBMCs(1x10
5
cell/well) from EN(n=16), GEO(n=16) and HO(n=6) individuals were left unstimulated 
(Cont.) or stimulated with OvAg (20µg/ml) or αCD3/αCD28(αCD3.,40,000 beads/well). After 7 days 
culture, cells were harvested and stimulated with PMA, Ionomycin, Brefeldin A and Monensin for 6 
hours and were stained for the Th17 transcription factor RORC2 and cytokine IL-17A. Each dot 
represents the mean percentage ± SD of CD4
+
RORC2
+
 and CD4
+
IL-17A
+
  T cell frequency. Data of 
each group were compared using Kruskal-Wallis and Mann-Whitney test and significant differences 
are given as *p< 0. 05 and ***p<0.001. 
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3.4.4. Increased Onchocerca volvulus-specific CD4+IL-10+ T cells in PBMCs 
cultures of HO individuals 
CD4+ T cells were shown to be the predominant IL-10 producing cells in filarial-
infected patients [114]. In cell culture supernatant, IL-10 was only observed at very 
low levels. (Figure 3.7H). In order to assess the expression of IL-10 and Foxp3 in 
the CD4+ T population, cells from EN, GEO and HO were cultured and left alone 
(Cont.) or stimulated with either αCD3/αCD28 (αCD3) or OvAg. After 7 days, cells 
were harvested and activated with PMA, Ionomycin, Brefeldin A and Monensin 
and 6 hours later, cells were stained and characterized by FACS. The OvAg 
stimulation slightly increased the expression of Foxp3 in CD4+ T cell populations 
compared to the unstimulated controls and this was significantly different in HO 
and its control (Figure 3.14A). No differences in expression of Foxp3 was 
observed among the groups before stimulation (Figure 3.14A) or after activation 
with either OvAg or αCD3/αCD28 (Figure 3.14B). Interestingly, in unstimulated 
cells from HO individuals, IL-10-producing CD4+ T cells were significantly elevated 
compared to other controls (Figure 3.14C). This was again significantly elevated in 
HO compared to EN and GEO after OvAg stimulation (Figure 3.14C). This 
phenotype did not changed upon TCR activation with  αCD3/αCD28 (Figure 
3.14D).   
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Figure 3.14: Increased Onchocerca volvulus-specific CD4+IL-10+ T cells in HO 
individuals.  
PBMCs from EN, GEO and HO individuals were left unstimulated (Cont.) or stimulated with OvAg 
(20µg/ml) or αCD3/αCD28 (αCD3.,40,000 beads/well ). After 7 days culture, cells were harvested 
and stimulated with PMA, Ionomycin, Brefeldin A and Monensin for 6 hours and were stained for 
Foxp3 and IL-10. Each dot represents the mean percentage ± SD of CD4
+
Foxp3
+
 (A, B) and 
CD4
+
IL-10
+
 (C,D) expression. Data of each group were compared using Kruskal-Wallis and Mann-
Whitney test and significant differences are given as *p< 0. 05,  **p< 0.01 and ***p<0.001. 
 
3.5. Antibody profiles in Onchocerca volvulus infected individuals 
The findings in section 3.2.1, showed that the frequencies of B cells was not 
different between EN, GEO and HO but memory T helper cells were elevated in 
HO individuals compared to the other groups. Further investigations highlighted 
the predominant Th2 and Th17 responses in HO patients. In this section, the role 
of B cell responses in hyperreactive onchocerciasis has been delineated using in 
vitro cell culture assays.  
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3.5.1. Elevated OvAg-specific IgG2, IgA and IgM in hyperreactive 
onchocerciasis 
In order to investigate filarial-specific IgG1, IgG2, IgG3, IgA and IgM antibody 
responses in HO individuals, PBMCs from Onchocerca volvulus-infected 
individuals (GEO and HO) and EN were left unstimulated (Cont.) or stimulated with 
either αCD3/αCD28 mAb microbeads (αCD3) or OvAg. Using a human 
Immunoglobulin Isotyping 6plex, levels of IgG1 and IgG2, IgG3, IgA and IgM were 
measured.  
There was no significant differences in the amounts of IgG1, IgG2 and IgG3 
secreted in the cell culture supernatants in any group either with or without 
stimulation (Figure 3.15A-F). Although levels of IgG3 were increased in EN and 
GEO individuals compared to the HO group upon activation with OvAg these 
levels were not significant (Figure 3.15A). The secretion of IgG2 was elevated in 
cultures from HO individuals compared to those from either EN or GEO groups 
after activation with OvAg (Figure 3.15D) and αCD3/αCD28 (Figure 3.15D). This 
data suggests that while OvAg-specific IgG2 induction is associated with 
hyperreactivity, IgG3 seems to be linked to protection in GEO and to putative 
immunity in EN. 
Regarding the secretion of IgA by activated B cells, the data showed a significant 
increase in IgA production in cultures from the HO group compared to EN and 
GEO upon OvAg stimulation (Figure 3.15G). IgA was also induced by the Ov 
antigen in cultures from EN individuals when compared to unstimulated controsl 
(Figure 3.15G and H). This was also the case upon T cell activation by 
αCD3/αCD28 since elevated amounts of IgA was observed in cultures from EN 
when compared to unstimulated controls (Figure 3.15H). Moreover, levels of IgA 
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were significantly increased in cultures from EN individuals when compared to 
either GEO or HO groups (Figure 3.15H). Interestingly, OvAg-stimulated B cells 
from HO to produced elevated amounts of IgM compared to its control and to 
activated cultures from EN and GEO groups (Figure 3.15I). This trend was similar 
after TCR activation (Figure 3.15G). These results indicate that IgA and IgM 
stimulated B cells may be involved in the disease pathogenesis of onchocerciasis.  
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Figure 3.15: Onchocerca volvulus antigen-specific antibodies induced in HO 
individuals.  
Peripheral blood mononuclear cells (PBMCs, 1x10
5
cell/well) from Endemic normal (EN, n=16), 
generalized onchocerciasis (GEO, n=16) and hyperreactive onchocerciasis (HO, n=6) individuals 
were thawed and stimulated either with Onchocerca volvulus-antigen (OvAg, 20µg/ml) or 
αCD3/αCD28 (αCD3, 40,000 beads/well ). After 14 days culture, supernatants were taken and 
levels of IgG1, IgG2, IgG3, IgA and IgM secretion were measured using a human Immunoglobulin 
Isotyping 6plex assay. Graphs show box whiskers with median, interquartile range and outliers. 
Data of each group were compared using Kruskal-Wallis and Mann-Whitney test and significant 
differences are given as *p<0, 05, **p<0, 01 and ***p<0,001. 
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3.5.2. Elevated IgE responses in hyperreactive onchocerciasis individuals 
In human filariasis, while IgG4 has been shown to be associated with 
immunomodulation, IgE has been linked to the development of pathology [6]. To 
assess the association of IgG4 and IgE in different clinical manifestations in 
human onchocerciasis, PBMCs from GEO, HO and EN were left unstimulated 
(Cont.) or stimulated with either αCD3/αCD28 (αCD3) or OvAg. After 14 days 
culture, supernatants were harvested and the induction of IgG4 and IgE were 
measured using Flowcytomix multiplex systems. While spontaneous release of 
IgG4 is higher in GEO compared to EN and HO (Figure 3.16A), OvAg stimulation 
induced significant increases of IgG4 in EN and GEO compared to their 
unstimulated controls (Figure 3.16A). No differences however were observed upon 
activation with αCD3/αCD28 between the three groups (Figure 3.16B). In contrast, 
basal secretion of IgE was increased in HO compared to GEO and HO (Figure 
3.16C). OvAg did not induce IgE production in HO but levels were increased in EN 
and GEO compared to controls (Figure 3.16C). Moreover, αCD3/αCD28 
stimulation did induce higher levels of IgE in cultures from HO and EN individuals 
when compared to unstimulated controls but no differences were observed 
amongst the groups (Figure 3.16D). The ratio IgE vs IgG4 was elevated in 
stimulated and non-stimulated PBMCs from HO compared to EN (Figure 3.16E-F).  
In concordance with the literature, these results indicate that IgE could be linked to 
disease manifestation while IgG4 is associated with protection in GEO individuals. 
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Figure 3.16: Elevated basal IgE and IgG4 levels in cell cultures from HO and GEO 
individuals respectively.  
PBMCs (1x10
5
cell/ml) from EN (n=16), GEO (n=16) and HO (n=6) individuals were left alone 
(cont.) or stimulated either with Onchocerca volvulus-antigen (OvAg, 20µg/ml) or 
αCD3/αCD28(αCD3, 40,000beads/well). After 14 days culture, supernatants were taken and 
secreted levels of IgG4 and IgE were measured by FlowCytomix Multiplex assays. Graphs show 
box whiskers with median, interquartile range and outliers. Data of each group were compared 
using Kruskal-Wallis and Mann-Whitney test and significant differences are given as *p<0, 05, 
**p<0, 01 and ***p<0,001. 
 
3.6. Onchocerca volvulus modulates Th17 cell generation in vitro 
In the previous sections, increased Th17 responses were associated with HO 
individuals compared to EN and GEO. Considering the characteristics of GEO 
compared to HO individuals (Table 1), GEO patients presented elevated numbers 
of nodules (implying higher worm load too) compared to HO who have little or no 
nodules. A possible scenario that could explain the differences in the levels of 
Th17 between both groups may be the modulation of immune response in GEO 
individuals by the adult worm. Indeed, helminth-derived antigens were shown to 
have a strong inhibitory effect on T helper cell commitment [8]. Therefore, using 
healthy donors, the modulation of Th17 responses by OvAg was studied in vitro. 
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3.6.1. IL-6 in combination with IL-1β induced Th17 cells polarization 
Th17 cells are committed in the presence of low levels of TGF-β and higher 
amounts of IL-6 in combination with IL-1β and IL-23 [135]. In order to generate IL-
17A producing CD4+ T cells in vitro, PBMCs were either left alone or stimulated 
with αCD3/αCD28 in the presence or absence of a chemokine cocktail (CC) 
containing IL-6 and IL-1β.  
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Figure 3.17: IL-6 in combination with IL-1β induces higher secretions of IL-17A.  
PBMCs(1x10
5
cells/ml) from European healthy donors (n=12) were left alone (Med) or stimulated 
with αCD3/αCD28 (20,000 beads/well) in the presence or absence of chemokine cocktail 
containing IL-6 and IL-1β (CC: IL-6, 10ng/ml and IL-1β, 5ng/ml). After 7 days culture, supernatants 
were taken and levels of IL-17A (A), IL-10 (B), IL-13 (C) and IFN-γ (D) were measured using 
ELISA. Bars represent mean ± SD of each cytokine level. Asterisks show statistical differences 
(Mann Whitney test) between the groups indicated by the brackets (*p<0.05, **p<0.01 and 
***p<0,001). 
 
The presence of the chemokine cocktail significantly induced the secretion of IL-
17A (Figure 3.17A). In contrast, no induction of either IL-10 (Figure 3.17B) or IL-13 
(Figure 3.17C) could be observed. Indeed, the combination of CC and 
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αCD3/αCD28 reduced IL-10 levels (Figure 3.17B). Moreover, these CC could also 
provoke significant release of IFN-γ (Figure 7D). This indicates that TCR activation 
in the presence of IL-6 and IL-1β could lead to the generation of Th17 cells and 
Th1 cells. 
3.6.2. Onchocerca volvulus adult antigen inhibits the induction of IL-17A by 
IL-6 and IL-1β 
To assess the immunomodulatory capacity of OvAg on Th17 cells development, 
PBMCs were either left unstimulated or activated with αCD3/αCD28 in an IL-6 and 
IL-1β milieu in the presence or absence of OvAg. Following 7 days culture, levels 
of IL-17A, IL-10, IL-13 and IFN-γ were measured. The addition of OvAg 
significantly down-regulated the secretion of both IL-17A (Figure 3.18A) and IL-13 
(Figure 3.18B) in the presence of IL-6 and IL-1β. In contrast, OvAg increased the 
induction of either IL-10 (Figure 3.18C) or IFN-γ (Figure 3.18D) compared to those 
without OvAg stimulation. These data suggest that OvAg could modulate or inhibit 
Th2 and Th17 responses.  
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Figure 3.18: Onchocerca volvulus adult antigen inhibits the induction of IL-17A.  
PBMCs (1x10
5
cells/ml) from European healthy donors (n=12) were left alone (Med) or stimulated 
with αCD3/αCD28 (20,000 beads/well) in a chemokine cocktail milieu containing IL-6 and IL-1β 
(CC: IL-6, 10ng/ml and IL-1β, 5ng/ml) in presence or absence of OvAg (12.5in p). After 7 days of 
culture, supernatants were removed and the induction of IL-17A (A), IL-13 (B), IL-10 (C) and IFN-γ ( 
D) were measured using ELISA. Bars represent mean ± SD of each cytokines level. Asterisks 
show statistical differences (Mann Whitney test) between the groups indicated by the brackets 
(**p<0.01 and ***p<0,001). 
 
3.6.3. Th2 and IL-10 cytokines reduces the secretion levels of IL-17A 
To investigate whether OvAg used Th2 or IL-10 pathways to inhibit the induction of 
IL-17A by IL-6 and IL-1β, PBMCs were either left unstimulated or activated with 
αCD3/αCD28 in the CC milieu and in addition, in the presence or absence of rhIL-
13, rhIL-4, rhIL-10 or with the combination of rhIL-4 and rhIL-13. The addition of 
each cytokine (Figure 3.19A, B and C) or a combination of IL-4 and IL-13 (Figure 
3.19D) significantly reduced the secretion of IL-17A suggesting that OvAg was 
modulating Th17 cell development using Th2 and/or IL-10 cytokine pathways.  
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Figure 3.19: Th2 or IL-10 cytokines reduce the secretion levels of IL-17A.  
1x10
5 
cells/ml of PBMCs from European healthy donors (n=12) were left alone (Med) or stimulated 
with αCD3/αCD28 (20,000 beads/well) in a chemokine cocktail milieu containing IL-6 and IL-1β 
(CC: IL-6, 10ng/ml and IL-1β, 5ng/ml) in the presence or absence of either (A) rhIL-13 (10ng/ml), 
(B) rhIL-4(10ng/ml), (C) rhIL-10(10ng/ml) or (D) with the combination of rhIL-4 and rhIL-13. After 7 
days culture, supernatants were removed and the induction of IL-17A was measured using ELISA. 
Bars represent mean ± SD of IL-17A levels. Asterisks show statistical differences (Mann Whitney 
test) between the groups indicated by the brackets (*p<0.05, **p<0.01 and ***p<0,001). 
 
3.6.4. Neutralizing Th2 related cytokines and IL-10 did not abolish the 
suppressive effect of OvAg on Th17 cells development  
In order to confirm the hypothesis that OvAg could use either Th2 and/or IL-10 
cytokine pathways to modulate Th17 cell development, PBMCs were either left 
unstimulated or activated with αCD3/αCD28 in an IL-6 and IL-1β milieu in the 
presence or absence of OvAg and neutralization antibodies against IL-13, IL-4 and 
IL-10 or respective isotype control. Blocking these cytokines (Figure 3.20A, B and 
C) or blocking them all simultaneously (Figure 3.20D) did not abolish the 
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suppressive effect of OvAg. This indicates that OvAg is using another pathway to 
modulate the development of Th17 cells.  
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Figure 3.20: Neutralizing Th2 related cytokines or IL-10 does not affect OvAg 
mediated suppressing of IL-17A production.  
1x10
5 
PBMCs/ml from European healthy donors (n=12) were left alone (Med) or stimulated with 
αCD3/αCD28 (20,000 beads/well) in a chemokine cocktail milieu containing IL-6 and IL-1β (CC: IL-
6, 10ng/ml and IL-1β, 5ng/ml) in the presence or absence of OvAg (12.5µg/ml) and neutralization 
antibodies against (A) IL-13 (αIL-13, 1µg/ml), (B) IL-4 (αIL-4, 1µg/ml), (C) IL-10 (αIL-10, 1µg/ml) 
and (D) with the combination of αIL-13, αIL-4 and αIL-10. Cultures were also stimulated in the 
presence of respective isotype controls. After 7 days culture, supernatants were removed and 
secretion of IL-17A was measured by ELISA. Bars represent mean ± SD of IL-17A levels. Asterisks 
show statistical differences (Mann Whitney test) between the groups indicated by the brackets 
(*p<0.05, and ***p<0,001). 
 
3.6.5. Indirect suppression of IL-17A secretion via monocytes but not B cells 
To assess at the cellular level the modulatory effect of OvAg on IL-17A production, 
PBMCs, T cells alone and co-cultures of T cells with either B cells or monocytes 
were either left unstimulated or activated with αCD3/αCD28 in an IL-6 and IL-1β 
milieu in the presence or absence of OvAg.  
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Figure 3.21: OvAg reduce IL-17A secretion by modulating monocytes. 
(A) PBMCs (1x10
5
cells/ml), (B) co-culture T cells (1x10
5
cells/ml) and Monocytes (1x10
5
cells/ml), 
(C) T cells alone(1x10
5
cells/ml) and (D)  co-culture of T cells and B cell (1x10
5
cells/ml) were either 
left unstimulated or activated with αCD3/αCD28 (20,000 beads/well) in a chemokine cocktail milieu 
containing IL-6 and IL-1β (CC: IL-6, 10ng/ml and IL-1β, 5ng/ml) in the presence or absence of 
OvAg (12.5µg/ml). After 7 days of culture, supernatants were screened for the secretion  of IL-17A 
by ELISA. Bars represent mean ± SD of IL-17A levels. Asterisks show statistical differences (Mann 
Whitney test) between the groups indicated by the brackets (*p<0.05). 
 
The suppressive trend of IL-17A observed with PBMCs after stimulation with OvAg 
(Figure 3.21A) was similar in co-cultures of T cell-monocytes (Figure 3.21B). In 
contrast, OvAg could not reduce IL-17A secretion with T cells alone or co-cultured 
with B cells (Figure 3.21C and D respectively). This indicates that OvAg did not 
interfere directly with T cells but acted on monocytes. 
3.7. Transformation of the GEO phenotype into a HO phenotype 
The mechanism underlining the development of HO phenotype in some individuals 
remains unclear. It was shown that Treg under inflammatory conditions could 
switch to Th17 responses [136-138]. Since the data showed that GEO individuals 
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have an elevated regulatory phenotype, in this section the following experiments 
describe potential pathways which could transform a regulatory  phenotype into a 
Th17 one in vitro by activating innate receptors. 
3.7.1. Increased pro-inflammatory cytokine secretion in cultures from GEO 
individuals after innate receptor stimulation 
The mechanisms underlining the differences observed between GEO and HO 
individuals is still not clearly defined. In section 3.1 and 3.2 of this study, it was 
shown that HO individuals, those with low MF load, exhibited strong pro-
inflammatory Th17 responses while GEO individuals, that is those with high MF 
load and adults worms, showed a strong regulatory phenotype. Therefore, PBMCs 
from EN and GEO individuals were stimulated with C12-iE-DAP (a PGN-like 
molecule, 100ng/ml) which is a NOD1 ligand, ODN 2006 (TLR9 ligand, 1µM), LPS 
(TLR4 ligand, 10ng/ml) and Muramyl dipeptide (10µg/ml), a NOD2 ligand for 7 
days to find out whether additional stimulation of these receptors could switch the 
GEO phenotype to a hyperreactive one. Interestingly, TLR4 stimulation  down-
regulated both IL-17A and IFN-γ  induction in cultures from GEO individuals (Figure 
3.22A and Figure 3.23A respectively). The data show that whilst NOD1L 
stimulation significantly increased IL-17A and IFN-γ production in GEO patients 
compared to EN (Figure 3.22B and Figure 3.23B respectively). Upon NOD2 
activation no effect was observed regarding IL-17A or IFN-γ secretion in cultures 
from GEO individuals when compared to EN (Figure 3.22C and Figure 3.23C 
respectively). TLR9 activation decreased IL-17A but not IFN-γ  production in GEO 
cultures compared to EN (Figure 3.22D and Figure 3.23D respectively). Moreover, 
the activation of either TLR4, NOD1 or NOD2 did not induce IL-4 secretion in 
either EN or GEO (Figure 3.24A, B and C). IL-4 induction was significantly 
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decreased in EN after TLR9 stimulation compared to control well but an increased 
level of this cytokine was observed in cultures from GEO compared to those from 
EN (Figure 3.24D). Regarding IL-10 secretion, no differences were observed after 
TLR4 activation (Figure 3.25A). An increase induction was seen in GEO compared 
to EN upon NOD1 and NOD2 stimulation (Figure 3.25B and C). TLR9-activated 
PBMCs did not induce any differential secretion amongst the groups (Figure 
3.25D). Overall, these data indicated that additional TLR4, TLR9 and NOD1 but 
not NOD2 stimulation could switch GEO phenotype to HO. 
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Figure 3.22: Increased IL-17A in GEO after NOD1 stimulation.  
PBMCs (1x10
5
cells/ml) from EN (n=7) and GEO (n=7) individuals were stimulated with (A) C12-iE-
DAP (PGN-like molecule, 100ng/ml) a NOD1 ligand, (B) ODN 2006 (TLR9 ligand, 1µM), (C) LPS 
(TLR4 ligand, 10ng/ml) and (D) Muramyl dipeptide (10µg/ml) a NOD2 ligand for 7 days and the 
secretion of IL-17A was measured by a Flowcytomix multiplex assay. Bars represent the mean ± 
SEM of IL-17A induction. Statistics were performed using 1way ANOVA. Asterisks show statistical 
differences between the groups indicated by the brackets (*p<0.05). 
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Figure 3.23: High IFN-γ in GEO upon NOD1, TLR9 and TLR4 stimulation.  
PBMCs(1x10
5
cells/ml) from EN (n=7) and GEO (n=7) individuals were activated with (A) C12-iE-
DAP (PGN-like molecule, 100ng/ml) a NOD1 ligand, (B) ODN 2006 (TLR9 ligand, 1µM), (C) LPS 
(TLR4 ligand, 10ng/ml) and (D) Muramyl dipeptide (10µg/ml) a NOD2 ligand for 7 days and the 
secretion of IFN-γ was measured using Flowcytomix multiplex assay. Bars represent the mean ± 
SEM of IFN-γ  induction. Statistics were performed using 1way ANOVA. Asterisks show statistical 
differences between the groups indicated by the brackets (*p<0.05). 
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Figure 3.24: Increased IL-4 in GEO after NOD2 and TLR9 activation. 
Cells (1x10
5 
cells/ml) from EN (n=7) and GEO (n=7) individuals were stimulated with (A) C12-iE-
DAP (PGN-like molecule, 100ng/ml) a NOD1 ligand, (B) ODN 2006 (TLR9 ligand, 1µM), (C) LPS 
(TLR4 ligand, 10ng/ml) and (D) Muramyl dipeptide (10µg/ml) a NOD2 ligand for 7 days and the 
secretion of IL-4 was measured by Flowcytomix. Bars represent the mean ± SEM of IL-4 induction. 
Statistics were performed using 1 way ANOVA. Asterisks show statistical differences between the 
groups indicated by the brackets (*p<0.05). 
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Figure 3.25: Augmented IL-10 in GEO upon NOD1 and NOD2 stimulation. 
PBMCs(1x10
5
cells/ml) from EN (n=7) and GEO (n=7) individuals were stimulated with (A) C12-iE-
DAP (PGN-like molecule, 100ng/ml) a NOD1 ligand, (B) ODN 2006 (TLR9 ligand, 1µM), (C) LPS 
(TLR4 ligand, 10ng/ml) and (D) Muramyl dipeptide (10µg/ml) a NOD2 ligand for 7 days and the 
secretion of IL-10 was measured by Flowcytomix. Bars represent the mean ± SEM of IL-10 
induction. Statistics were performed using 1way ANOVA.  
 
3.7.2. IL-6 and IL-1β induced IL-17A and IFN-γ in GEO and EN respectively 
In section 3.8, the triggering of NOD and TLRs elicited the induction of IL-17A 
production in PBMCs from GEO individuals. In order to assess the mechanism by 
which additional TLR4, TLR9 and NOD1 stimulation induced the secretion of IL-
17A and IFN-γ in cell cultures from GEO individuals, cells from EN and GEO were 
activated with αCD3/αCD28 in the presence of IL-6 and IL-1β. After 7 days of 
culture, IL-17A, IFN-γ, IL-4 and IL-10 were measured from cell culture 
supernatants. Significant increases of IL-17A and IFN-γ were observed in cultures 
from EN and GEO groups when comparing unstimulated controls with those with 
TCR activation in the presence of IL-6 and IL-1β (Figure 3.26A and B). The 
secretion of IL-17A was higher in cultures from GEO individuals when compared to 
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EN (Figure 3.26A). This was not the case for IFN-γ since levels were increased in 
EN compared to GEO group (Figure 3.26B). No differences were observed 
regarding IL-4 secretion (Figure 3.26C) but IL-10 was higher in EN cultures 
compared to GEO after addition of IL-6 and IL-1β (Figure 3.26D). These findings 
could suggest that TLRs and NLRs activation induce IL-6 and IL-1β secretion that 
in turn polarizes T helper cells towards a proinflammatory Th17 or Th1 phenotype. 
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Figure 3.26: Increased IL-17A and IFN-γ secretion in GEO and EN.  
Cells from EN (n=5) and GEO (n=5) were left unstimulated (cont.) or stimulated with αCD3/αCD28 
in the presence or absence of the chemokine cocktail containing IL-6 and IL-1β (CC: IL-6, 10ng/ml 
and IL-1β, 5ng/ml). After 7days incubation, supernatants were harvested and the induction of  IL-
17A(A), IFN-γ (B), IL-4(C) and IL-10(D) were measured by Flowcytomix multiplex assay. Bars 
indicate mean ± SEM levels of each cytokine. Asterisks show statistical differences (1 way ANOVA 
and Mann Whitney test) between the groups (*p<0.05, **p<0.01 and ***p<0.001). 
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4. Discussion 
In this study, infection free volunteers living in the endemic area for at least 10 
years and were MF negative, had no palpable onchocercomas and no pathology 
related to onchocerciasis (EN) and infected individuals with either i) palpable 
nodules, higher worm burden and mild or no pathology (GEO) or ii) less or no 
palpable nodules, low worm burden and severe pathology (HO) were recruited. 
The implication of Th1, Th2 and Treg responses in human onchocerciasis is 
widely investigated but the role of the recently characterized pro-inflammatory 
Th17 cells in this disease remains unclear. Therefore, the present study aimed at 
characterizing Th17 cells and investigating whether the balance of Th17/Treg is a 
possible cause for the different clinical manifestations in human onchocerciasis. 
Using flow cytometry and PCR array, the data presented in chapter 3 showed that 
hyperreactive individuals have elevated Th17 responses associated with Th2 
responses, whereas GEO individuals exhibited a strong regulatory phenotype and 
endemic normals presented elevated Th1 responses. To support these findings, 
filarial-specific responses in these groups were also investigated in vitro using an 
antigen extract prepared from Onchocerca volvulus worms.  Furthermore, the 
mechanisms underlining differences between GEO and HO individuals was 
studied. These data have provided evidence that the adult worms may down-
regulate Th17 responses in GEO individuals which is not possible in the HO group 
since these individuals have very low or even no adult worms. In the final section, 
the transformation of a GEO phenotype to a HO phenotype was investigated after 
stimulating cells from GEO and EN individuals with TLRs and NLRs ligands. 
Overall, the study demonstrated that the regulatory phenotype of GEO patients 
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could be switched to a pro-inflammatory Th17 state upon additional triggering of 
innate receptors. In this section, all findings and observations are discussed. 
4.1. Immune cell profiles in hyperreactive Onchocerca volvulus-infected 
individuals 
Hyperreactive onchocerciasis cases are extremely infrequent, approximately 1% 
of the infected population and the underlying etiology remains unclear [12, 139]. In 
this study, the cellular immune profiles of GEO, HO and EN individuals was 
compared and provided initial evidence that an accentuated Th2/Th17 phenotype 
forms part of the immune network which the drives  hyperreactive  state. Th1 cells 
on the other hand are clearly no longer involved at this stage of pathogenesis 
since T-bet+ and IFN-γ producing CD4+ T cells were observed at significantly lower 
levels when compared to EN. The association of IFN-γ and putative immunity in 
endemic-residing individuals has been demonstrated in studies investigating 
reactions to L3 larvae [70]. On the other hand, Cooper et al., demonstrated that 
early exposure to O. volvulus infection elicited elevated IFN-γ responses to OvAg 
but not L3 larvae [53]. Since recent reports have suggested that Wolbachia, the 
endosymbiotic bacteria in O. volvulus and other filarial species, were the principal 
activator of innate and Th1 inflammatory immunity [35], these responses may stem 
from exposure to worms and/or bacteria.  
Previous studies have noted that HO individuals present elevated numbers of 
peripheral leucocytes and eosinophils but not neutrophils [94, 140]. Moreover, an 
inverse chemotactic responsiveness was determined in eosinophils and 
neutrophils in HO patients supporting the hyporesponsive phenotype in GEO 
patients [140]. Upon analysis of other immune cell subsets Brattig et al. [94], found 
no differences in CD19+ B cells and expanding on those findings we now observed 
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no alterations in the frequencies of memory B cells (CD19+CD27+) either. GEO 
individuals did present however reduced numbers of CD8+ T cells, NK and NKT 
cells when compared to EN. Due to a higher worm burden in GEO individuals and 
thus increased amounts of circulating helminth-derived glycolipids and 
glycoproteins, there may be increased migration of NKT cells into the skin 
resulting in decreased numbers in blood. HO and GEO individuals on the other 
hand displayed lower numbers of CD16brightCD56dim and CD16dimCD56bright NK 
cells. Different combinations of CD56 and CD16 on NK cells can reflect their 
function. For example, studies have shown that whereas CD56dim cells have high 
cytotoxic activity, CD56bright cells produce cytokines such as IFN-γ. Thus, O. 
volvulus-infected individuals had reduced populations of both NK fractions. In 
contrast, EN individuals presented elevated IFN-γ producing T cells and Ov-
specific re-stimulation and therefore, further studies may reveal that the elevated 
CD16dimCD56bright NK cells are producing IFN-γ too. The actual role of NK cells in 
extracellular parasitic infections, including filarial infections, is not well-defined 
although studies with the murine model of filariasis, Litomosoides sigmodontis, 
have shown that depletion of NK cells enhanced worm load and Th2 responses at 
the site of infection [141].  Previous in vitro investigations using PBMCs from 
healthy individuals demonstrated that NK activation and consequential apoptosis 
resulted from contact with IL-12 producing monocytes after stimulation with filarial 
antigens [142]. Therefore, the marked increase of monocytes in HO individuals 
observed in this study could be initiated by i) an elevated requirement of 
phagocytosis due to increased apoptotic material, ii) increased stimulation due to 
dying or dead filarial material or iii) simply elevated APC requirement due to 
elevated hyperreactivity.  
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An elevated requirement of antigen presentation in HO individuals would correlate 
to their marked increase in memory CD4+ T cells (CD4+CD45RO+), an 
immunological difference not previously reported between the two polar versions 
of O. volvulus infection. In association, CD45RO+ cells were observed via immuno-
histochemistry in nodules from sowda individuals [139]. Correspondingly, there 
was a significant decrease in CD4+CD45RA+ T cells in HO patients when 
compared to GEO and EN individuals. Previously, Freedman et al., reported a 
similar finding in MF+ O. volvulus-infected individuals, which significantly 
decreased after ivermectin therapy [118]. Further studies also showed increased 
IFN-γ and IL-5 but decreased IL-10 production in filarial-stimulated PBMC cultures 
from GEO individuals following therapy [102]. IL-10 plays a substantial role in 
mediating immune responses, suppressing the growth and function of numerous 
cells types [143]. As mentioned previously, elevated IL-10 levels are synonymous 
with a regulatory phenotype (high IgG4 and increased Treg) in GEO individuals [6, 
144]. Comparisons of Ov-stimulated PBMCs from MF+ and amicrofilaridermic 
(aMF) patients revealed that cell cultures from MF+ patients made more IL-10 than 
those isolated from a-MF individuals. Furthermore, following regression analysis 
this was shown to be associated with the presence of MF and the number of times 
an individual had received ivermectin [51]. The study presented here is the first to 
compare the cytokine production of PBMCs from GEO and HO individuals 
following re-stimulation in vitro. Interestingly, although IL-5 and IL-13 levels were 
markedly increased in cultures from HO individuals, levels of IL-10 were equal. 
However, via flow cytometry, it was revealed that GEO individuals had a much 
higher frequency of IL-10+CD4+ T cells than HO. CD4+ T cells have been shown to 
be the largest producers of IL-10 in O. volvulus-infected individuals and although 
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nearly a fifth of those cells further secreted IL-4 hardly any produced IFN-γ. 
Moreover, IL-10-producing Tr1 cells cloned from subcutaneous tissue surrounding 
the onchocercomas secreted TGF-β but failed to produceIL-2 and only low levels 
of IL-4 and IFN-γ if at all [144]. Moreover, the observed hyporesponsiveness was 
directed towards OvAg and not antigens derived from other filarial species 
indicating T cell mediated Ov-specific down regulation. Interestingly, the addition 
of IL-10 or TGF-β neutralizing antibodies to OvAg stimulated PBMCs cultures 
significantly elevated the proliferative responses in GEO individuals [53, 144].  
In association with higher IL-10 and strong regulatory phenotype, Foxp3+ and 
TGF-β+ cells have been  identified in situ within nodules of GEO but not HO 
individuals via immuno-histochemistry [69, 145],  Upon analysis of Treg, the 
number of Foxp3+ T cells in the CD4+ T cell compartment was higher in HO 
individuals but analysis of CD25hiFoxp3+ T cell subsets revealed a higher number 
of these Treg in GEO patients [146, 147]. These data imply therefore, that HO 
individuals have elevated CD4+Foxp3+ conventional T cells that are perhaps not 
regulatory [148]. Interestingly, in correlation, gene expression levels of Foxp3 in 
the PCR array were also higher in the HO individuals and here, cells were not 
stimulated with the stimulation cocktail. These data reflect the hyperresponsive 
profiles of these patients. To date it remains unclear whether naturally-occurring or 
induced Treg are required for steering or regulating human filarial infection. 
Alongside, higher levels of IL-10, GEO individuals are also associated with IgG4 
secretion [129]. The propensity to drive IgG4 production has been shown to be 
mediated by Foxp3+Treg [120] and moreover, was shown to be dependent on 
GITR-GITRL interaction, IL-10 and TGF-β [120]. In further studies it was shown 
that prior activation of B cells with TLR4 and TLR9 but not TLR2 hindered the 
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ability of Treg to dampen Ig secretion in B cells and promoted the production of IL-
6 and IL-1β. Moreover, under inflammatory conditions, Treg retained Foxp3 
expression but up-regulated RORC2 and secreted IL-17A [130]. Therefore, during 
microbial infection, B cells could potentially escape Treg control which provides an 
explanation as to why patients suffering from allergy or helminth disease display 
polar immunological symptoms despite being exposed to the same agent.  
4.2. Elevated balance of Th17/Treg in HO individuals 
A central focus of this thesis work was to investigate whether there were changes 
in the balance between T helper responses and regulatory T cells in the polar 
forms of onchocerciasis. As anticipated, a prominent Treg phenotype was 
associated with GEO individuals whereas Th1 and Th2 responses were more 
dominant in EN. Interestingly, the ratio of Th17/Treg, Th17/Th2 and Th17/Th1 
populations were increased in HO individuals compared EN and GEO. The 
implication of Th17 in clinical manifestations in onchocerciasis has not been 
clearly delineated.  In this study, Th17 cells were shown to be dominant in HO 
individuals. This suggests that the balance Th17/Treg could play an important role 
in the pathological outcome of human onchocerciasis. 
4.3. Confirmation of the dominant Th17/Th2 phenotype through gene 
analysis. 
The predominance of Th17 responses in patients with severe pathology was 
confirmed by the significantly higher expression of RORC2 and IL-17 in CD4+ T 
cells from these patients at both protein and genomic levels. Th17 cell lineages 
are promoted by the inhibition of Foxp3 by IL-6 and simultaneous elevation of 
TGF-β and IL-1β responses. IL-1β, especially in synergy with IL-23, plays an 
essential role in the induction and expansion of murine and human Th17 cells 
 77  
 
[135, 149].  Using a Th17 based PCR array, all of these essential Th17-related 
genes were up-regulated in HO individuals. These included IL-17 family members 
and IL-22, IL-23A, IL-21. More interestingly, the Th17 transcription factor and 
signalling pathway molecule RORC2 and STAT3 genes were also up-regulated. In 
contrast, CCR6 which is known to be important for Th17 cell homing [150] was 
down-regulated in HO individuals. Further investigation will elucidate these 
findings. Interestingly, a suppressor of cytokine signaling (SOCS3) gene that has 
been shown to suppress STAT3 pathway and therefore inhibit Th17 cell 
commitment [151] was down-regulated in HO compared to GEO. Tregs associated 
genes such us CCL1 and IL-7R were also under-expressed in HO. Indeed, IL-7R 
signaling contributes to Treg cell development and peripheral homeostasis [152] 
and chemokine ligand 1 (CCL1) is critical for the maintenance of Treg function 
[153]. In correlation with elevated Th1 responses in GEO compared to HO, Th1-
related genes such as IL-12β and IL-12Rβ were overregulated in GEO compared 
to HO. These findings suggest that the implication of Th17 cells in the pathology of 
human onchocerciasis is regulated at genomic level.  
4.4. Onchocerca volvulus antigen-specific responses in infected 
individuals 
A major finding in this present study is the dominant Th17/Th2 phenotype in HO 
individuals. Indeed, upon re-stimulation with Ov antigen, PBMCs from HO patients 
secreted significant amounts of IL-5 and especially IL-13. In contrast, IL-4 was not 
detectable in the cell culture supernatants and its expression in CD4+ T cells after 
intracellular staining did not reflect the phenotype observed in HO individuals after 
direct FACS analysis. This could be due to: i) IL-4, as a growth factor, was 
immediately used by the cells, ii) the strong activation with PMA boosts the 
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transcription factor but not the cytokine secretion or iii) since cells from HO 
individuals are hyperreactive, a negative feedback control at the transcriptional 
level could occur after in vitro activation of the cells. These data correlate to earlier 
studies showing an increased likelihood of developing sowda in persons carrying 
the Arg110 variant of IL-13 which leads to higher IL-13 signalling [154]. Th2 
responses in filarial infections have been linked to infection resistance [154, 155] 
and MF elicit pro-inflammatory responses when they are degenerated or moribund 
[156]. Thus, a potential scenario for developing hyper-responsiveness may be that 
deviated Th2 responses provoke MF death which in turn induces a Th17 
phenotype (Figure 4.1). In fact, IL-17A-secreting CD4+ T cells were 4 times higher 
in HO individuals when compared to either EN or GEO groups. Interestingly, 
although IL-17A, IL-22 and IL-1β responses were low upon Ov antigen stimulation, 
levels were significantly higher in cell cultures from HO individuals upon TCR 
activation. The increase of IL-6, IL-22 and IL-1β upon αCD3/αCD28 stimulation 
could favour the commitment of Th17 responses since IL-17A was also strongly 
induced after TCR activation. The induction of IL-6 after activation with OvAg may 
indicate that the parasite could indirectly induce Th17 cell development via the IL-6 
pathway. These data indicate that all Th responses (Th1/Th2/Th17) are 
uncontrolled in HO patients when compared to GEO groups.  
In lymphatic filariasis, Th17 cells have been implicated in lymphatic inflammation 
and are prominent in patients who have cleared bloodstream MF [157]. Indeed, 
increased antigen-specific Th17 responses were observed in individuals with 
chronic lymphoedema [116]. Since patients with elevated Th17 responses in LF 
have less circulating MF it raises the question as to whether MF directly down-
regulate Th17 responses to extend their survival. A recent study on Schistosoma 
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haematobium-infected individuals has also revealed an association between Th17 
responses and enhanced bladder pathology [115]. Nevertheless, despite the 
association of pathology and Th17 cells, our findings differ from those studies in 
two regards. First, patients presenting filarial lymphoedema, had elevated Th1 and 
Th17 responses following filarial-specific re-stimulation but no alteration in the 
amount of secreted IL-10 [116]. In the study of S. haematobium-infected children 
[115], Tregs frequencies were equal amongst the infected and control groups 
whereas in the HO cohort studied here, individuals had reduced numbers of IL-
10+CD4+ and CD25hiFoxp3+CD4+ Tregs when compared to the GEO group. In 
association, asymptomatic W. bancrofti-infected individuals also presented higher 
levels of Foxp3+ on the mRNA level but only after re-stimulation with filarial antigen 
[116]. Thus, although Th17-producing cells appear to be a common dominator in 
helminth-infected individuals displaying severe pathology each infection appears 
to have created its own subtle collaboration of immune parameters such as Treg, 
IL-10 and in HO accentuated Th2 responses as well. OvAg and αCD3/αCD28 
activation did not induced IL-10 secretion in CD4+ T cells. This is not in line with 
the literature since Infection with filarial parasites is associated with T cell 
hyporesponsiveness, which is thought to be partly mediated by their ability to 
induce regulatory T cells (Treg) during human infections and also filarial-specific 
IL-10 was pointed to play a role in the suppression of effector T cells response 
[111, 112, 146, 158].  T cell receptor activation showed increase IL-5, IL-13 and 
IFN-γ production in cultures from the HO group when compared to GEO 
individuals, this could be explained by: i) hyperresponsiveness state and ii) 
modified Th1 or Th2 responses. In association with the data shown in Figure 3.2A, 
cells from EN secreted significantly more IFN-γ upon activation with Ov-antigen 
 80  
 
and levels were significantly higher than those produced by cells from HO 
individuals. However, the dampened IFN-γ responses from cells of HO individuals 
was not reflected upon αCD3/αCD28 activation since here significantly higher 
levels were observed when compared to both EN and GEO groups, indicating that 
failure to produce IFN-γ was not a deficit of Th1 cells per se but dampened filarial-
specific IFN-γ-producing cells (Figure 3.7D).  
In order to confirm the antigen-specific Th cells cytokine profiles observed in cell 
culture supernatants and since IL-4 was not detectable, OvAg-activated PBMCs 
from different study groups were stained intracellulary for IFN-γ, IL-4, IL-17A and 
IL-10. All these cytokines could be observed via flow cytometry analysis but did 
not correlate with cell culture supernatant data.  
Another novelty and interesting finding in this study was the increased antigen-
specific IL-9 secretion in HO individuals upon stimulation with OvAg. Indeed,  
interleukin-9 is believed to induce Th17 cell differentiation, enhance the function of 
natural regulatory T cells; hence plays an important role in pro-inflammatory 
diseases and the regulation of the immune system [159, 160]. The induction of 
Th9 cells in EN and HO may indicate that these cells are involved in the clearance 
of the parasite since GEO individuals that harbor higher worm burdens fail to 
induce OvAg-specific Th9 responses. This is in concordance with the literature 
since the combination of Th17 and Th9 responses were shown in inflammatory 
conditions [134, 161] and also Th17 cells were shown to secrete IL-9 [162, 163].       
4.5. Antibodys profiles in Onchocerca volvulus-infected individuals 
Antibody-mediated immunity plays an important role in helminth infection and is 
also associated with different clinical manifestation [164]. Therefore, antibodiy 
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profiles were assessed in the cell culture supernatants of HO individuals against 
EN and GEO. The role of IgA and IgM in hyperreactive onchocerciasis is not well 
investigated. Here, IgA and IgM were shown to be linked in the elevated pathology 
of human onchocerciasis. Further investigations are needed however to 
completely define the function or activity of these antibodies in filariasis. The 
combination of Th2 and Th17 responses might activate B cells to preferentially 
produce IgA and IgM. This also has to be further investigated. In this study, HO 
individuals presented increased levels of the Th17-related cytokine IL-6 which has 
been shown to induce IgA and IgM secretion by B cells [165, 166]. Interestingly, 
IL-17A was shown to be determinant in antibody production by B cells but the 
exact role remains unclear [167]. 
Upon OvAg stimulation, IgG2, IgG4, IgA and IgM were increased in cultures from 
HO individuals when compared to levels in cultures from EN and GEO groups. 
Interestingly, increased spontaneous release of IgG4 and IgE was observed in 
cultures from GEO and HO individuals respectively while IgG3 was high in just the 
"medium" or control supernatant of EN. Taken together, these results  suggest that 
IgG2 and IgE are not only associated with the clearance of the parasite in HO 
individuals but could lead to the skin inflammation observed in this group. Base 
line release of IgG4 in GEO could explain the regulatory state of these individuals, 
while IgG3 in the "medium" of EN-derived cell cultures may be associated with 
protection and immunity against the larval stage. Indeed, It has been reported that 
in onchocerciasis, FC receptor and complement-binding IgG3 levels are higher in 
EN compared with those in GEO who are characterized by elevated IgG4 
antibodies [168]. In contrast, high sera levels of IgE, IgG1, IgG2, IgG3 were 
observed in sowda individuals (HO) [169]. 
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A new finding associated with this study is the increased levels of OvAg-specific 
IgM and IgA that seems to be associated with the clearance of the parasites, an 
area which warrants further investigation in Onchocerca infections. Elevated 
concentrations of IgM and IgA were observed in sera from Onchocerca volvulus-
infected patients from Sudan [170].  
4.6. OvAg modulated Th17 cells polarization in vitro 
The immunomodulatory properties of helminth-derived antigens is well 
documented [171]. Here we found that individuals with high MF load and adult 
worms (GEO) have diminished Th17 responses while people with less or no MF 
and adult worms (HO) develop strong Th17 responses. The question was whether 
adult worms, in order to survive, down-regulate Th17 responses in GEO people. 
To test this, adult worm antigen extract was use in vitro to block Th17 cell 
polarization. The development and function of Th17 cells requires TCR activation 
in the presence of cytokines such as IL-6 and IL-1β [133]. In this study, it was 
found that the combination of IL-6 and IL-1β (CC) upon TCR activation increased 
IL-17A secretion.  This higher induction of IL-17A was down-regulated when OvAg 
was added to the system. In addition, Th2 cytokines were also down-regulated but 
there was an increase in IL-10 and IFN-γ secretion. This suggests the potential of 
adult worm antigen to modulate not only the development of Th17 responses but 
also the Th2 responses. Indeed, O. volvulus antigen components have been 
implicated in the down-regulation of effector actions of both Th1 and Th2 
responses [172]. The induction of regulatory cells that produce IL-10 and/or TGF-β 
has been demonstrated in several studies to be the mechanism used by helminths 
to regulate the immune system [173]. Here, we observed that OvAg increased Th1 
cytokines and IL-10 in the presence of CC. Therefore, we hypothesized that the 
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modulation of Th17 cells polarization was through Th1, IL-10 and Th2 pathway 
although IL-13 was down-regulated in the presence of OvAg. The addition of  rhIL-
4, rhIL-13, rhIL-10 or all together in the absence of OvAg decreased IL-17A 
secretion. This is in line with literature since Th2 and Th17 responses are known 
to be antagonist [174]. Rui He et al. demonstrated that in the absence of Th2 
cytokines, IL-17A responses to epicutaneous sensitization mediated airway 
inflammation was exaggerated [175]. In contrast, the addition of anti-IL-4, anti-IL-
13 and anti-IL-10 in the presence of OvAg did not restore the secretion of IL-17A 
suggesting that OvAg used neither IL-4, IL-13 nor IL-10 pathways to modulate 
Th17 cell development. To further elucidate this phenomenon, it was hypothesized 
that OvAg may directly act on T cells, or indirectly on antigen-presentation cells 
(APC). Therefore, T cells, alone or T cells in co-culture with B cells or monocytes 
were activated with αCD3/αCD28 in the presence of CC and OvAg. It was 
observed that when cultured alone or in presence of B cells, OvAg did not down-
regulate the induction of IL-17A in CC. However, OvAg could down-regulate IL-
17A secretion in T-monocytes co-culture. This indicates that OvAg may suppress 
the antigen presenting capacity of monocytes to modulate Th17 cell development.  
4.7. Additional innate receptors stimulation switch GEO phenotype to HO 
In O. volvulus endemic areas, the existence of the two polar forms of the disease 
is still not fully understood. The question was therefore, whether there is a group of 
people who can only develop GEO or HO phenotype or is there a dynamic switch 
from GEO to HO? Soboslay et al. and others have demonstrated that children 
born from infected mothers develop GEO while those from non-infected mother 
manifest severe pathology form of the disease, suggesting a maternal imprinting of 
the permissiveness [8, 176]. Gene polymorphism influences clinical manifestation 
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in helminth infection and immune heterogeneity arises not from hosts and 
parasites in isolation, but also from the environment in which immune responses 
develop [177]. For instance VEGF-A gene polymorphism was shown to be 
associated with the development of hydrocele in lymphatic filariasis [178]. In 
human onchocerciasis, Fc gamma RIIa gene polymorphism has been  implicated 
in the development of severe reactive onchodermatitis [179]. To study the 
transformation of GEO to HO, cells from GEO individuals were activated with TLR 
and NLR ligands. Here it was seen that the stimulation of TLR4, NOD1 and NOD2 
could switch a GEO phenotype into a HO one as reflected by the increased 
expression of IL-17A and IFN-γ cytokines in the GEO group. More interestingly, the 
addition of recombinant human IL-6 and IL-1β induced a significant increase of IL-
17A secretion in cultures from GEO individuals when compared to EN indicating 
that: i) TLR and NLR activation induced these cytokines which in turn could 
change a GEO phenotype into a HO one by transforming the existing Tregs in 
GEO to Th17 cells and ii) O. volvulus infection did not suppress the host innate 
immune system. In vitro studies using recombinant IL-12 and IL-18 showed that 
while IL-18 could reduce antigen-specific IL-10 secretion in cells from O. volvulus-
infected individuals, IL-12 re-directed antigen responsiveness by promoting IFN-γ 
production [180]. All together, these observations may suggest that in addition to 
genetic polymorphism the different polar forms of infection outcomes observed 
following O. volvulus infection are driven by external factors such as bacterial 
infection that apparently activate innate receptors. Such findings point to the 
importance of co-infection towards the elimination of filarial infection globally. 
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4.8. Conclusion 
This thesis aimed at characterizing the role of Th17 cells and the assessing 
whether the balance of Th17/Treg were possible causes in the differential clinical 
manifestations in human onchocerciasis. The data showed that while GEO 
individuals are characterized by increased regulatory responses shown by higher 
CD4+CD25hiFoxp3+ T cells and IL-10 CD4+ T producing cells, HO individuals 
exhibited strong Th17 and Th2 responses with elevated ratios of Th17/Treg. 
Interestingly, the Th1 phenotype was the only characteristic response of EN. The 
antigen-specific responsiveness of cells from the study groups indicated increased 
Th1 and Th2 responses in EN and GEO respectively. This work highlights the 
possible underlying mechanisms between GEO and HO. Here OvAg significantly 
mediated in vitro development of Th17 cells by transforming a GEO phenotype 
into a HO phenotype following activation of innate receptors which lead to 
increased production of cytokines such as IL-6 and IL-1β. The study also indicates 
that the strong Th17 responses observed in PBMCs was not specific to O.v. adult 
worm antigen. This raises the question whether other components of the worm 
could induce this response. Therefore there is the need for further investigations 
into other possible inducers of Th17 responses such as the endosymbiont 
Wolbachia and possibly microfilariae antigen. Also the role of IgM and IgA in 
onchocerciasis has to be further delineated. Due to the lack of a suitable murine 
model for the complete life-cycle of O. volvulus parasite, the study could not 
confirm the findings using animal models. For these reasons, the findings might 
not reflect the whole human immune activity in onchocerciasis. Figure 4.1 
represents a model that describes different mechanisms that can drive the 
 development of Th17 responses in HO individuals and could explain in
makes the difference between HO
Figure 4.1:  Development of T helper 17 responses in 
infection.  
Onchocerca volvulus infection can lead to two polar forms: generalized onchocercia
hyperreactive onchocerciasis (HO). (A)
produce TGF-ß that polarize T cells to regulatory T cells (Treg). Additional infection or the release 
of bacterial  endosymbiont Wolbachia
(TLRs) or Nod-like receptors (NLRs) on DCs to release IL
naive helper T cells to Th17.  (B)
DCs to release IL-6, IL-1ß and TGF
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 GEO. Parasites  could activate dendritic cells (DCs) to 
 after anti-filaria treatment  could activate Toll
-6 and IL-1ß that may transform Treg
 HO. In addition to the latter pathway, the parasite can stimule 
-ß that could polarize T helper cells toward Th17 responses.
-depth what 
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6. APPENDIX 
Appendix A: EQUIPMENTS 
 
Equipments 
 
Company, city and country 
BD FACS CantoTM flow cytometer BD Biosciences, Heidelberg, Germany 
Cellstar 96-Well Cell Culture Plate, 
sterile, U-bottom, with lid 
Greiner bio-one, Frickenhausen, Germany 
Cellstar serological pipette, 
5mL, 10mL 
Greiner bio-one, Frickenhausen, Germany 
Cellstar Tubes (15ml, 50ml) Greiner bio-one, Frickenhausen, Germany 
Centrifuge  Kendro, Langenselbold, Germany 
Costar Stripette, serological 
pipette, 25mL 
Corning Incorporated, Corning, New York, 
USA 
Cryo Tubes  
 
Thermo Scientific, Roskilde, Denmark 
Falcon serological pipette, 50 mL Becton Dickinson Labware, Franklin Lakes, 
NJ. USA 
Freezer (-20°C) AEG, Nürnberg, Germany 
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Freezer (-80°C) AEG, Nürnberg, Germany 
Fridge Liebherr, Biberach an der Riss, Germany 
Glass Pasteur Pipette Brand GmbH + CO, Wertheim, Germany 
Incubator Kendro, Langenselbold, Germany 
Lamina Flow hood Kendro, Langenselbold, Germany 
MACS multistand separator Miltenyi BiotecGmbH, Bergisch Gladbach, 
Germany 
MACS separation columns  Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
Micropipette Eppendorf Research Eppendorf AG, Hamburg, Germany 
Microscope Leica Mikrosysteme Vertrieb GmbH, 
Wetzlar, Germany 
Primus Thermocycler MWG-Biotech, Ebersberg, Germany 
Multichannel pipette (m300) Biohit, Göttingen, Germany 
Multipette stream Eppendorf AG, Hamburg, Germany 
Neubauer counting chamber Marienfeld, Lauda Königshofen, Germany 
Pipetboyacu Integra Biosciences, Fernwald, Germany  
PS Microplates Greiner bio-one, Frickenhausen, Germany 
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Plate reader SpectraMAX 340 Pc Molecular Devices 
NanoDrop 1000 Peqlab, Erlangen, Germany 
Round-Bottom Tubes (5mL) Becton Dickinson Labware, Franklin Lakes, 
NJ. USA 
Safe-Lock Tubes (0.5-2ml) Eppendorf AG, Hamburg, Germany 
Tip One, pipette tips Starlab Group, Hamburg, Germany 
Vacuum pump ABM Greiffenberger, Marktredwitz, Germany 
Vortex mixer (Minishaker) VWR International, Darmstadt, Germany 
Water bath VWR International, Darmstadt, Germany 
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Appendix B: Chemicals and Reagents 
Reagents Company, city and country  
Advanced RPMI 1640 (1x) Life Technologies Corporation, Grand 
Island, NY, USA 
Anti-Human CD25 FITC Ebioscience, San Diego, USA 
Anti-Human CD25 PE-Cy7 Ebioscience, San Diego, USA 
Anti-Human CD4 APC Ebioscience, San Diego, USA 
Anti-Human CTLA-4 PE Ebioscience, San Diego, USA 
Anti-Human Foxp3 PE Ebioscience, San Diego, USA 
Anti-Human IFNƳ PE Ebioscience, San Diego, USA 
Anti-Human IL-10 Immuno Tools, Friesoythe, Germany 
Anti-human IL-13 Immuno Tools, Friesoythe, Germany 
Anti-Human IL-17A PE Ebioscience, San Diego, USA 
Anti-Human IL-4 Immuno Tools, Friesoythe, Germany 
Anti-Human IL-4 PE Ebioscience, San Diego, USA 
C12-iE-DAP, Human NOD1 ligand InvivoGen, San Doiego, USA 
CD14 MicroBeads, human Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
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CD19 MicroBeads, human Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
CD3/CD28 MACSiBead Particles Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
CD4 MicroBeads, human Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
CD4+CD25+CD127dim/-  
Reg. T Cell Isolation Kit II 
Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
Cell stimulation Cocktail plus 
golgiStop 
Ebioscience, San Diego, USA 
Coomassie blue G Cytoscelecton, Denver, USA 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich, Steinheim, Germany 
DNA-free  
Dulbecco’s PBS Life Technologies Corporation, Paisley, UK 
Dynabeads Human T-Activator 
CD3/CD28 
Invitrogen Dynal, Oslo, Norway 
Fetal Calf Serum, Standard Quality PAA Laboratories GmbH, Pasching, Austria 
Fixation/Permeabilization 
Concentrate 
ebioscience, San Diego, USA 
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Fixation/Permeabilization Diluent ebioscience, San Diego, USA 
Gentamycin (50 mg mL-1) PAA Laboratories GmbH, Pasching, Austria 
HKLM, Human TLR2 ligand InvivoGen, San Doiego, USA 
Human 13-plex cytokines Kit Ebioscience, San Diego, USA 
Human Immunoglobulin Isotyping 
Panel 6-plex Kit 
Ebioscience, San Diego, USA 
Human Immunoglobulin simplex 
IgE Kit 
Ebioscience, San Diego, USA 
L-Glutamine 200 mM (100x) Life Technologies Corporation, Grand 
Island, NY, USA 
LPS-EK, Human TLR4 ligand InvivoGen, San Doiego, USA 
MACS Separation Buffer Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
Master mix Quiagen GmbH, Hilden, Germany 
MDP, Human NOD2 ligand InvivoGen, San Doiego, USA 
Normal Rat Serum Ebioscience, San Diego, USA 
ODN 2006 Human TLR9 ligand InvivoGen, San Doiego, USA 
Pam3CSK, Human TLR1/2 ligand InvivoGen, San Doiego, USA 
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Pancoll Human (1,077 g mL-1) PAN Biotech, Aidenbach, Germany 
Penicillin Streptomycin 
 
Life Technologies Corporation, Grand 
Island, NY, USA 
Permeabilization Buffer (10x) Ebioscience, San Diego, USA 
Recombinant Human Interleukin-10 Immuno Tools, Friesoythe, Germany 
Recombinant Human Interleukin-13 Immuno Tools, Friesoythe, Germany 
Recombinant Human Interleukin-1β Immuno Tools, Friesoythe, Germany 
Recombinant Human Interleukin-4 Immuno Tools, Friesoythe, Germany 
Recombinant Human Interleukin-6 Immuno Tools, Friesoythe, Germany 
Trizol Invitrogen 
Trypan blue 2 % in PBS  
Ultra Comp ebeads Ebioscience, San Diego, USA 
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Appendix C: FACS staining antibodies 
Antibodies Clone Company, city and 
country  
Anti-Human CD14-FITC 61D3 Ebioscience, San Diego, 
USA 
Anti-Human CD16-FITC CB16 Ebioscience, San Diego, 
USA 
Anti-Human CD19-APC HIB19 Ebioscience, San Diego, 
USA 
Anti-Human CD25-PE-Cy7 BC96 Ebioscience, San Diego, 
USA 
Anti-Human CD27-FITC  Ebioscience, San Diego, 
USA 
Anti-Human CD3-PerCP 
Cy5.5 
OKT3 Ebioscience, San Diego, 
USA 
Anti-Human CD45RA-
PerCPCy5.5 
HI100 Ebioscience, San Diego, 
USA 
Anti-Human CD45RO-FITC UCHL Ebioscience, San Diego, 
USA 
Anti-Human CD4-APC OKT4 Ebioscience, San Diego, 
USA 
Anti-Human CD56-PE CMSSB Ebioscience, San Diego, 
USA 
Anti-Human CD8-APC SK1 Ebioscience, San Diego, 
USA 
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Anti-Human Foxp3 PE 236A/E7 Ebioscience, San Diego, 
USA 
Anti-Human GATA3-PE JWAJ Immuno Tools, Friesoythe, 
Germany 
Anti-Human IFNƳ PE 4S.B3 Ebioscience, San Diego, 
USA 
Anti-Human IL-10-PE JES3-9D7 Immuno Tools, Friesoythe, 
Germany 
Anti-Human IL-17A-FITC AFKJS-9 Ebioscience, San Diego, 
USA 
Anti-Human IL-4-PE B-S4 Ebioscience, San Diego, 
USA 
Anti-Human RORC2-PE AFKJS-9 Ebioscience, San Diego, 
USA 
Anti-Human T bet-PE eBio64DE17 Ebioscience, San Diego, 
USA 
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Appendix D: Software 
BD FACSDiver software, BD Biosciences, Heidelberg, Germany 
SoftMax Pro 5.0 software, Molecular Devices, Ismning, Germany 
RT2 profiler PCR Array data analysis 3.5 software, Qiagen, Hilden, Germany 
PRISM 5.02, GraphPad Software, Inc., La Jolla, USA 
Appendix E:  Buffers and Solutions  
Cell culture medium 
500ml RPMI 1640 medium  
5ml Penicillin (100µg/ml)/Streptomycin (100µg/ml) 
0.5 ml Gentamycin  (50µg/ml) 
5ml L-glutamine (292.3µg/ml) 
10% FCS 
For 50ml: 5ml FCS + 45ml RPMI 1640 culture medium with antibiotics 
Coating buffer (ELISA) 
0.1M of NaHCO3 
For 1 liter: 8.4g NaHCO3 in 900ml distilled water, adjust the PH to 9.6 using KOH, 
then top to 1 liter                                               
Blocking buffer (ELISA) 
Assay diluent (5x), dilution 1:5 
For 200ml; 40ml assay diluents 5x + 160ml distilled water 
FACS Buffer 
1xPBS with 2 % FCS 
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 PFA  4% solution (FACS) 
40g of PFA dissolved while heating (max 60°C) in 900ml 1x PBS. Increase 
solubility by adding NaOH dropwise, top to 1 liter with 1x PBS. Solution then 
cooled and filtered. Adjust pH to 6.9 using dilute HCl. 
Fixation/Permeabilisation Buffer 
1:4 dilution 
For 12ml: 3ml Fix/perm concentrate + 9ml dilution buffer 
 Permeabilization Buffer 
1:10 dilution 
For 50ml: 5 ml 10x permeabilisation buffer + 45ml distilled water 
Stop Solution 2N H2SO4 
½ Liter: 26,6ml H2SO4 +473ml distilled water 
Wash buffer 
 For 5 liters: 
 weigh out 47.75g of PBS 
  Fill up with distilled water 
  2.5ml Tween 80 
  adjust pH 7.2-7.4 
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Appendix F: PCR Array. Gene table 
Position Symbol Description Gene name 
A01 CCL1 Chemokine (C-C motif) ligand 1 I-309/P500/SCYA1/SISe/TCA3 
A02 CCL2 Chemokine (C-C motif) ligand 2 GDCF-2/HC11/HSMCR30/MCAF/MCP-1/MCP1/SCYA2/SMC-CF 
A03 CCL20 Chemokine (C-C motif) ligand 20 CKb4/LARC/MIP-3-alpha/MIP-3a/MIP3A/SCYA20/ST38 
A04 CCL22 Chemokine (C-C motif) ligand 22 ABCD-1/DC/B-CK/MDC/SCYA22/STCP-1 
A05 CCL7 Chemokine (C-C motif) ligand 7 FIC/MARC/MCP-3/MCP3/NC28/SCYA6/SCYA7 
A06 CCR2 Chemokine (C-C motif) receptor 2 CC-CKR-2/CCR-2/CCR2A/CCR2B/CD192/CKR2/CKR2A/CKR2B/CMKBR2/MCP-1-R 
A07 CCR4 Chemokine (C-C motif) receptor 4 CC-CKR-4/CD194/CKR4/CMKBR4/ChemR13/HGCN:14099/K5-5 
A08 CCR6 Chemokine (C-C motif) receptor 6 BN-1/C-C CKR-6/CC-CKR-6/CCR-6/CD196/CKR-L3/CKRL3/CMKBR6/DCR2/DRY6/Y4/STRL22
A09 CD28 CD28 molecule Tp44 
A10 CD34 CD34 molecule - 
A11 CD4 CD4 molecule CD4mut 
A12 CD40LG CD40 ligand CD154/CD40L/HIGM1/IGM/IMD3/T-BAM/TNFSF5/TRAP/gp39/hCD40L 
B01 CD8A CD8a molecule CD8/Leu2/MAL/p32 
B02 CEBPB CCAAT/enhancer binding protein (C/EBP), beta C/EBP-beta/CRP2/IL6DBP/LAP/LIP/NF-IL6/TCF5 
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B03 CLEC7A C-type lectin domain family 7, member A BGR/CANDF4/CLECSF12/DECTIN1 
B04 CSF2 Colony stimulating factor 2 (granulocyte-macrophage) GMCSF 
B05 CSF3 Colony stimulating factor 3 (granulocyte) C17orf33/CSF3OS/GCSF 
B06 CX3CL1 Chemokine (C-X3-C motif) ligand 1 ABCD-3/C3Xkine/CXC3/CXC3C/NTN/NTT/SCYD1/fractalkine/neurotactin 
B07 CXCL1 Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) FSP/GRO1/GROa/MGSA/MGSA-a/NAP-3/SCYB1 
B08 CXCL12 Chemokine (C-X-C motif) ligand 12 IRH/PBSF/SCYB12/SDF1/TLSF/TPAR1 
B09 CXCL2 Chemokine (C-X-C motif) ligand 2 CINC-2a/GRO2/GROb/MGSA-b/MIP-2a/MIP2/MIP2A/SCYB2 
B10 CXCL5 Chemokine (C-X-C motif) ligand 5 ENA-78/SCYB5 
B11 CXCL6 Chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) CKA-3/GCP-2/GCP2/SCYB6 
B12 FOXP3 Forkhead box P3 AIID/DIETER/IPEX/PIDX/XPID 
C01 GATA3 GATA binding protein 3 HDR/HDRS 
C02 ICAM1 Intercellular adhesion molecule 1 BB2/CD54/P3.58 
C03 ICOS Inducible T-cell co-stimulator AILIM/CD278/CVID1 
C04 IFNG Interferon, gamma IFG/IFI 
C05 IL10 Interleukin 10 CSIF/GVHDS/IL-10/IL10A/TGIF 
C06 IL12B Interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) CLMF/CLMF2/IL-12B/NKSF/NKSF2 
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C07 IL12RB1 Interleukin 12 receptor, beta 1 CD212/IL-12R-BETA1/IL12RB 
C08 IL12RB2 Interleukin 12 receptor, beta 2 - 
C09 IL13 Interleukin 13 IL-13/P600 
C10 IL15 Interleukin 15 IL-15 
C11 IL17A Interleukin 17A CTLA8/IL-17/IL-17A/IL17 
C12 IL17C Interleukin 17C CX2/IL-17C 
D01 IL17D Interleukin 17D IL-17D/IL-27/IL27 
D02 IL17F Interleukin 17F CANDF6/IL-17F/ML-1/ML1 
D03 IL17RA Interleukin 17 receptor A CANDF5/CD217/CDw217/IL-17RA/IL17R/hIL-17R 
D04 IL17RB Interleukin 17 receptor B CRL4/EVI27/IL17BR/IL17RH1 
D05 IL17RC Interleukin 17 receptor C IL17-RL/IL17RL 
D06 IL17RE Interleukin 17 receptor E - 
D07 IL18 Interleukin 18 (interferon-gamma-inducing factor) IGIF/IL-18/IL-1g/IL1F4 
D08 IL1B Interleukin 1, beta IL-1/IL1-BETA/IL1F2 
D09 IL1R1 Interleukin 1 receptor, type I CD121A/D2S1473/IL-1R-alpha/IL1R/IL1RA/P80 
D10 IL2 Interleukin 2 IL-2/TCGF/lymphokine 
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D11 IL21 Interleukin 21 IL-21/Za11 
D12 IL22 Interleukin 22 IL-21/IL-22/IL-D110/IL-TIF/ILTIF/TIFIL-23/TIFa/zcyto18 
E01 IL23A Interleukin 23, alpha subunit p19 IL-23/IL-23A/IL23P19/P19/SGRF 
E02 IL23R Interleukin 23 receptor - 
E03 IL25 Interleukin 25 IL17E 
E04 IL27 Interleukin 27 IL-27/IL-27A/IL27A/IL27p28/IL30/p28 
E05 IL3 Interleukin 3 (colony-stimulating factor, multiple) IL-3/MCGF/MULTI-CSF 
E06 IL4 Interleukin 4 BCGF-1/BCGF1/BSF-1/BSF1/IL-4 
E07 IL5 Interleukin 5 (colony-stimulating factor, eosinophil) EDF/IL-5/TRF 
E08 IL6 Interleukin 6 (interferon, beta 2) BSF2/HGF/HSF/IFNB2/IL-6 
E09 IL6R Interleukin 6 receptor CD126/IL-6R-1/IL-6RA/IL6Q/IL6RA/IL6RQ/gp80 
E10 IL7R Interleukin 7 receptor CD127/CDW127/IL-7R-alpha/IL7RA/ILRA 
E11 IL8 Interleukin 8 CXCL8/GCP-1/GCP1/LECT/LUCT/LYNAP/MDNCF/MONAP/NAF/NAP-1/NAP1 
E12 IL9 Interleukin 9 HP40/IL-9/P40 
F01 IRF4 Interferon regulatory factor 4 LSIRF/MUM1/NF-EM5 
F02 ISG20 Interferon stimulated exonuclease gene 20kDa CD25/HEM45 
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F03 JAK1 Janus kinase 1 JAK1A/JAK1B/JTK3 
F04 JAK2 Janus kinase 2 JTK10/THCYT3 
F05 MMP3 Matrix metallopeptidase 3 (stromelysin 1, progelatinase) CHDS6/MMP-3/SL-1/STMY/STMY1/STR1 
F06 MMP9 Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) CLG4B/GELB/MANDP2/MMP-9 
F07 NFATC2 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 NFAT1/NFATP 
F08 NFKB1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 EBP-1/KBF1/NF-kB1/NF-kappa-B/NF-kappaB/NFKB-p105/NFKB-p50/NFkappaB/p105/p50 
F09 RORA RAR-related orphan receptor A NR1F1/ROR1/ROR2/ROR3/RZR-ALPHA/RZRA 
F10 RORC RAR-related orphan receptor C NR1F3/RORG/RZR-GAMMA/RZRG/TOR 
F11 RUNX1 Runt-related transcription factor 1 AML1/AML1-EVI-1/AMLCR1/CBFA2/EVI-1/PEBP2aB 
F12 S1PR1 Sphingosine-1-phosphate receptor 1 CD363/CHEDG1/D1S3362/ECGF1/EDG-1/EDG1/S1P1 
G01 SOCS1 Suppressor of cytokine signaling 1 CIS1/CISH1/JAB/SOCS-1/SSI-1/SSI1/TIP3 
G02 SOCS3 Suppressor of cytokine signaling 3 ATOD4/CIS3/Cish3/SOCS-3/SSI-3/SSI3 
G03 STAT3 Signal transducer and activator of transcription 3 (acute-phase response factor) APRF/HIES 
G04 STAT4 Signal transducer and activator of transcription 4 SLEB11 
G05 STAT5A Signal transducer and activator of transcription 5A MGF/STAT5 
G06 STAT6 Signal transducer and activator of transcription 6, interleukin-4 induced D12S1644/IL-4-STAT/STAT6B/STAT6C 
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G07 SYK Spleen tyrosine kinase p72-Syk 
G08 TBX21 T-box 21 T-PET/T-bet/TBET/TBLYM 
G09 TGFB1 Transforming growth factor, beta 1 CED/DPD1/LAP/TGFB/TGFbeta 
G10 TLR4 Toll-like receptor 4 ARMD10/CD284/TLR-4/TOLL 
G11 TNF Tumor necrosis factor DIF/TNF-alpha/TNFA/TNFSF2 
G12 TRAF6 TNF receptor-associated factor 6 MGC:3310/RNF85 
H01 ACTB Actin, beta BRWS1/PS1TP5BP1 
H02 B2M Beta-2-microglobulin - 
H03 GAPDH Glyceraldehyde-3-phosphate dehydrogenase G3PD/GAPD 
H04 HPRT1 Hypoxanthine phosphoribosyltransferase 1 HGPRT/HPRT 
H05 RPLP0 Ribosomal protein, large, P0 L10E/LP0/P0/PRLP0/RPP0 
H06 HGDC Human Genomic DNA Contamination HIGX1A 
H07 RTC Reverse Transcription Control RTC 
H08 RTC Reverse Transcription Control RTC 
H09 RTC Reverse Transcription Control RTC 
H10 PPC Positive PCR Control PPC 
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H11 PPC Positive PCR Control PPC 
H12 PPC Positive PCR Control PPC 
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